Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
IPSC.midbrain_primed: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,442 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Household income | SOCIO000026 | 195.68 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 2 | Social and economic stability | SOCIO000028 | 168.05 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 3 | Leg mass | BCOMP000017 | 163.53 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 4 | SLC35G2 levels | PROLV001879 | 159.66 | Protein levels | Neural / glial | 0 | 2 | 4 | 6 | |
| 5 | Fat-free mass | BCOMP000008 | 147.50 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 6 | Basal metabolic rate | METBL000007 | 146.42 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 7 | Body water mass | BCOMP000006 | 143.58 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 8 | Trunk mass | BCOMP000019 | 141.86 | Body composition | Stromal / connective | 381 | 4 | 10 | 14 | |
| 9 | Reproductive timing | BEHAV000011 | 136.50 | Behavioural | Neural / glial | 48 | 5 | 9 | 16 | |
| 10 | Arm mass | BCOMP000014 | 122.93 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 11 | Whole body impedance | BCOMP000007 | 106.12 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 12 | Pain, neck and shoulder | MSKEL000039 | 105.02 | Musculoskeletal | Myeloid | 0 | 4 | 9 | 20 | |
| 13 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 105.02 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 14 | Spread preference | DTSUP000018 | 102.37 | Diet and Supplement | Neural / glial | 14 | 2 | 6 | 13 | |
| 15 | Cognitive function | PSYCH000002 | 100.71 | Psychiatric | Neural / glial | 282 | 3 | 5 | 17 | |
| 16 | Processing speed | PSYCH000008 | 99.96 | Psychiatric | Neural / glial | 65 | 4 | 10 | 18 | |
| 17 | IZUMO4 levels | PROLV001123 | 96.32 | Protein levels | Myeloid | 2 | 3 | 10 | 21 | |
| 18 | Paroxysmal neurological disorder | NEURO000035 | 94.93 | Neurologic | Neural / glial | 21 | 3 | 4 | 10 | |
| 19 | Sciatica | NEURO000033 | 92.99 | Neurologic | Neural / glial | 12 | 6 | 11 | 26 | |
| 20 | Thigh muscle volume | BMORP000020 | 92.76 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 21 | Pain, chronic | MSKEL000034 | 91.91 | Musculoskeletal | Neural / glial | 29 | 5 | 9 | 29 | |
| 22 | Pain, none | MSKEL000041 | 91.76 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 23 | SEZ6 levels | PROLV001840 | 90.23 | Protein levels | Neural / glial | 1 | 3 | 9 | 20 | |
| 24 | Leg impedance | BCOMP000016 | 89.81 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 25 | Bowel function | GASTR000002 | 85.78 | Gastrointestinal | Neural / glial | 18 | 5 | 9 | 11 | |
| 26 | PER3 levels | PROLV001537 | 85.30 | Protein levels | Muscle / cardiac | 5 | 3 | 10 | 17 | |
| 27 | CFH levels | PROLV000413 | 85.00 | Protein levels | Stromal / connective | 20 | 4 | 12 | 18 | |
| 28 | Medication, laxative | GASTR000016 | 81.01 | Gastrointestinal | Myeloid | 0 | 2 | 4 | 15 | |
| 29 | Occupational physical activity | BEHAV000006 | 80.95 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 30 | Frailty, poorer cognition | PSYCH000001 | 79.68 | Psychiatric | Neural / glial | 40 | 2 | 7 | 9 | |
| 31 | Arm fat percentage | BCOMP000012 | 79.61 | Body composition | Neural / glial | 328 | 4 | 7 | 13 | |
| 32 | Medication use, pain etc, none | MISCL000032 | 79.38 | Miscellaneous | Neural / glial | 13 | 4 | 10 | 4 | |
| 33 | Sexually transmitted infection | IMMUN000072 | 79.24 | Immunologic | Granulosa cell | 7 | 4 | 9 | 30 | |
| 34 | Leg fat percentage | BCOMP000015 | 78.31 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 35 | Oesophageal disorder | GASTR000050 | 77.33 | Gastrointestinal | Neural / glial | 15 | 2 | 10 | 21 | |
| 36 | Weight | BMORP000015 | 76.82 | Body morphology | Neural / glial | 1,549 | 3 | 8 | 22 | |
| 37 | Brainstem volume | NIMAG000017 | 76.81 | Neuroimaging | Neural / glial | 10 | 3 | 5 | 15 | |
| 38 | EHMT2 levels | PROLV000691 | 76.79 | Protein levels | Granulosa cell | 1 | 3 | 10 | 14 | |
| 39 | Vehicle ownership | SOCIO000015 | 75.08 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 40 | Panic attack | PSYCH000031 | 72.80 | Psychiatric | Muscle / cardiac | 0 | 1 | 7 | 4 | |
| 41 | Hearing loss, age-related | AUDIO000006 | 72.64 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 42 | Sleep duration | PSYCH000040 | 72.43 | Psychiatric | Neural / glial | 9 | 6 | 14 | 17 | |
| 43 | SPESP1 levels | PROLV001926 | 71.96 | Protein levels | Lymphocyte | 3 | 3 | 11 | 18 | |
| 44 | Heart failure, congestive | CARDI000004 | 70.58 | Cardiac | Muscle / cardiac | 6 | 2 | 5 | 14 | |
| 45 | Exercise workload | CARDI000024 | 68.45 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 46 | Medication use | MISCL000037 | 67.30 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 47 | Sexual behaviour | BEHAV000012 | 66.99 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 48 | Intelligence | PSYCH000004 | 65.68 | Psychiatric | Neural / glial | 305 | 2 | 3 | 13 | |
| 49 | Body mass index, BMI | BMORP000002 | 64.19 | Body morphology | Neural / glial | 1,808 | 5 | 9 | 17 | |
| 50 | Rotator cuff disorder | MSKEL000066 | 62.71 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 8 | |
| 51 | Alcohol consumption | PSYCH000041 | 62.48 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 52 | Diabetes, type 2 with complication | METBL000033 | 61.13 | Metabolic | Neural / glial | 118 | 2 | 8 | 8 | |
| 53 | Household size | SOCIO000011 | 60.74 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 54 | Fat mass | BCOMP000005 | 59.98 | Body composition | Neural / glial | 607 | 3 | 8 | 21 | |
| 55 | Luteinizing hormone | ENDOC000008 | 59.96 | Endocrine | Muscle / cardiac | 0 | 5 | 7 | 15 | |
| 56 | Hand grip strength | MSKEL000030 | 59.40 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 57 | Medication, angiotensin receptor blocker | VASCU000029 | 59.10 | Vascular | Adipose | 0 | 1 | 8 | 19 | |
| 58 | Neuroticism | PSYCH000034 | 58.79 | Psychiatric | Neural / glial | 77 | 3 | 6 | 12 | |
| 59 | Narcolepsy | NEURO000036 | 56.47 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 60 | Frailty, general | MISCL000039 | 56.29 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 61 | Loose teeth | DENTA000012 | 55.34 | Dental | Neural / glial | 1 | 2 | 7 | 12 | |
| 62 | Electronic device use | BEHAV000017 | 54.00 | Behavioural | Neural / glial | 29 | 3 | 8 | 21 | |
| 63 | Lean mass | BCOMP000009 | 53.52 | Body composition | Stromal / connective | 897 | 4 | 7 | 8 | |
| 64 | PRSS8 levels | PROLV001648 | 53.22 | Protein levels | Epithelial | 26 | 1 | 5 | 8 | |
| 65 | Hip circumference | BMORP000011 | 52.72 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 66 | Healthcare cost | SOCIO000025 | 52.06 | Socioeconomic | Neural / glial | 27 | 3 | 8 | 12 | |
| 67 | PSRC1 levels | PROLV001662 | 51.85 | Protein levels | Myeloid | 26 | 3 | 10 | 17 | |
| 68 | Reaction time | PSYCH000010 | 50.83 | Psychiatric | Neural / glial | 67 | 3 | 6 | 11 | |
| 69 | Dietary change | DTSUP000006 | 50.31 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 0 | |
| 70 | Sedentary behaviour | BEHAV000008 | 49.77 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 71 | Physical function | MISCL000041 | 49.58 | Miscellaneous | Stromal / connective | 502 | 3 | 4 | 9 | |
| 72 | Diabetes, with complication | METBL000035 | 48.31 | Metabolic | Neural / glial | 74 | 1 | 4 | 9 | |
| 73 | Consultant specialty, anaesthetics | MISCL000015 | 48.08 | Miscellaneous | Neural / glial | 0 | 4 | 7 | 15 | |
| 74 | Heart rate | CARDI000021 | 47.71 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 75 | PCSK9 levels | PROLV001512 | 47.32 | Protein levels | Hepatocyte | 87 | 1 | 5 | 8 | |
| 76 | Administrative status | MISCL000021 | 47.27 | Miscellaneous | Neural / glial | 0 | 2 | 8 | 13 | |
| 77 | F7 levels | PROLV000748 | 46.89 | Protein levels | Hepatocyte | 89 | 1 | 8 | 15 | |
| 78 | Sodium | METAB000050 | 46.71 | Metabolites | Neural / glial | 189 | 3 | 8 | 9 | |
| 79 | ECG QRS-T angle | CARDI000033 | 46.13 | Cardiac | Muscle / cardiac | 57 | 2 | 4 | 10 | |
| 80 | Headache | NEURO000009 | 45.61 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 81 | Hearing loss, sensorineural | AUDIO000008 | 45.42 | Auditory | Neural / glial | 38 | 2 | 9 | 8 | |
| 82 | Waist circumference | BMORP000013 | 45.21 | Body morphology | Neural / glial | 286 | 5 | 8 | 19 | |
| 83 | Water consumption | DTSUP000004 | 44.35 | Diet and Supplement | Neural / glial | 104 | 3 | 4 | 14 | |
| 84 | THBS4 levels | PROLV002027 | 43.45 | Protein levels | Hepatocyte | 69 | 2 | 8 | 18 | |
| 85 | DHX58 levels | PROLV000617 | 43.30 | Protein levels | Hepatocyte | 1 | 4 | 9 | 28 | |
| 86 | Educational attainment | SOCIO000002 | 43.22 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 87 | Professional qualification | SOCIO000003 | 43.10 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 88 | Neurodegenerative disorder | NEURO000021 | 42.13 | Neurologic | Myeloid | 59 | 2 | 12 | 9 | |
| 89 | AXIN1/CDKN1A ratio | PRORT000166 | 40.62 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 90 | Occupational attainment | SOCIO000007 | 40.47 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 91 | Gastritis and duodenitis | GASTR000049 | 40.09 | Gastrointestinal | Neural / glial | — | 2 | 7 | 5 | |
| 92 | Peripheral vascular disease | VASCU000043 | 39.31 | Vascular | Stromal / connective | 65 | 3 | 6 | 14 | |
| 93 | Dorsopathy | MSKEL000075 | 39.26 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 94 | Family history, chronic lung disease | RESPI000002 | 38.97 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 95 | Digital deformity | MSKEL000053 | 38.68 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 96 | Cerebellar volume | NIMAG000019 | 38.54 | Neuroimaging | Myeloid | 12 | 0 | 0 | 1 | |
| 97 | Self-rated health | MISCL000013 | 38.39 | Miscellaneous | Neural / glial | 29 | 5 | 10 | 17 | |
| 98 | ACE2 levels | PROLV000011 | 38.01 | Protein levels | Hepatocyte | 128 | 2 | 10 | 17 | |
| 99 | Retirement wellbeing | SOCIO000027 | 37.88 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 100 | Barrett's oesophagus | GASTR000046 | 37.78 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 101 | GLB1/PCSK9 ratio | PRORT001217 | 37.76 | Protein ratios | Hepatocyte | 90 | 3 | 15 | 19 | |
| 102 | Family history, dyslipidaemia | METBL000010 | 37.67 | Metabolic | Hepatocyte | 64 | 1 | 6 | 10 | |
| 103 | Medication, anti-depressant | PSYCH000019 | 37.52 | Psychiatric | Neural / glial | 5 | 3 | 8 | 8 | |
| 104 | Obesity | METBL000008 | 36.84 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 105 | Sleep behaviour | BEHAV000016 | 36.74 | Behavioural | Neural / glial | 57 | 4 | 8 | 7 | |
| 106 | SERPINF1 levels | PROLV001832 | 36.37 | Protein levels | Vascular | 7 | 0 | 6 | 8 | |
| 107 | Dyspnoea | RESPI000028 | 36.12 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 108 | Open wound | DERMA000043 | 36.06 | Dermatologic | Neural / glial | 1 | 3 | 7 | 6 | |
| 109 | Pain, back | MSKEL000033 | 35.06 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 110 | Fasciectomy | MSKEL000045 | 34.28 | Musculoskeletal | Stromal / connective | 11 | 3 | 8 | 14 | |
| 111 | Pregnancy complication, general | REPRO000029 | 34.08 | Reproductive | Hepatocyte | 3 | 2 | 6 | 12 | |
| 112 | GDF15 levels | PROLV000869 | 34.03 | Protein levels | Hepatocyte | 7 | 1 | 8 | 27 | |
| 113 | Educational attainment, none | SOCIO000001 | 33.86 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 114 | ADAMTSL2 levels | PROLV000036 | 33.62 | Protein levels | Hepatocyte | 72 | 3 | 14 | 23 | |
| 115 | Sex-differentiated cardiometabolic traits | MISCL000002 | 33.57 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 116 | Respiratory symptom | RESPI000032 | 33.13 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 117 | Household composition | SOCIO000010 | 33.11 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 118 | Abdominal and pelvic pain | GASTR000043 | 32.89 | Gastrointestinal | Neural / glial | 0 | 4 | 7 | 13 | |
| 119 | IL13RA1 levels | PROLV001047 | 32.85 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 120 | IFIH1 levels | PROLV001015 | 32.22 | Protein levels | Vascular | 0 | 2 | 7 | 7 | |
| 121 | LAYN/ULBP2 ratio | PRORT001435 | 31.82 | Protein ratios | Neural / glial | 3 | 1 | 8 | 13 | |
| 122 | CDKN1A/TBL1X ratio | PRORT000573 | 31.70 | Protein ratios | Hepatocyte | 13 | 3 | 13 | 13 | |
| 123 | C3 levels | PROLV000232 | 31.30 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 124 | Optic disc area | OPHTH000029 | 31.20 | Ophthalmic | Vascular | 11 | 4 | 7 | 13 | |
| 125 | GPRC5C levels | PROLV000930 | 31.20 | Protein levels | Hepatocyte | 102 | 1 | 6 | 11 | |
| 126 | Polycythaemia | HEMAT000012 | 31.08 | Hematologic | Vascular | 2 | 2 | 7 | 14 | |
| 127 | Weight, birth | BMORP000018 | 30.99 | Body morphology | Vascular | 117 | 2 | 6 | 16 | |
| 128 | Food preparation preference | DTSUP000021 | 30.69 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 129 | Body size, adult | BMORP000003 | 30.67 | Body morphology | Stromal / connective | 300 | 3 | 6 | 8 | |
| 130 | Ventricular function | CARDI000008 | 30.61 | Cardiac | Muscle / cardiac | 84 | 2 | 4 | 12 | |
| 131 | Diabetes, general | METBL000030 | 30.54 | Metabolic | Hepatocyte | 973 | 1 | 5 | 8 | |
| 132 | Arm impedance | BCOMP000013 | 30.54 | Body composition | Stromal / connective | 665 | 4 | 6 | 12 | |
| 133 | Pregnancy complication, vomiting | REPRO000035 | 30.36 | Reproductive | Lymphocyte | 0 | 1 | 8 | 25 | |
| 134 | Cereal preference | DTSUP000010 | 30.29 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 135 | Joint disorder | MSKEL000015 | 30.09 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 136 | Ventricular wall thickness | CARDI000016 | 29.91 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 137 | Worry | PSYCH000032 | 29.79 | Psychiatric | Neural / glial | 94 | 2 | 3 | 5 | |
| 138 | NSFL1C/PSMG3 ratio | PRORT001599 | 29.74 | Protein ratios | Neural / glial | 19 | 4 | 7 | 20 | |
| 139 | Atherosclerosis | VASCU000006 | 29.57 | Vascular | Hepatocyte | 177 | 2 | 10 | 20 | |
| 140 | Occupation | SOCIO000006 | 29.54 | Socioeconomic | Neural / glial | 1 | 1 | 4 | 6 | |
| 141 | Musculoskeletal soft tissue disorder | MSKEL000029 | 29.18 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 142 | Non-cancer illness burden | MISCL000029 | 29.13 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 143 | Cardiomyopathy | CARDI000040 | 29.05 | Cardiac | Muscle / cardiac | 51 | 2 | 3 | 3 | |
| 144 | HbA1c | METBL000039 | 28.98 | Metabolic | Hematopoietic progenitor | 970 | 0 | 3 | 10 | |
| 145 | ASGR1/DCBLD2 ratio | PRORT000147 | 28.87 | Protein ratios | Hepatocyte | 92 | 3 | 9 | 19 | |
| 146 | Hearing difficulty | AUDIO000012 | 28.87 | Auditory | Neural / glial | 134 | 1 | 7 | 6 | |
| 147 | PBLD levels | PROLV001500 | 28.50 | Protein levels | Muscle / cardiac | 5 | 6 | 18 | 62 | |
| 148 | Psychiatric disorder | PSYCH000016 | 28.26 | Psychiatric | Neural / glial | 0 | 2 | 7 | 11 | |
| 149 | BCAN/NPTXR ratio | PRORT000219 | 28.13 | Protein ratios | Stromal / connective | 9 | 1 | 6 | 7 | |
| 150 | Sun exposure | BEHAV000001 | 27.79 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 151 | Cortical volume | NIMAG000022 | 27.78 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 152 | COL4A1 levels | PROLV000490 | 27.57 | Protein levels | Hepatocyte | 117 | 3 | 10 | 16 | |
| 153 | Vegetable preference | DTSUP000020 | 27.56 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 154 | Eye disorder | OPHTH000008 | 27.44 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 155 | Obstetric trauma | REPRO000039 | 27.33 | Reproductive | Lymphocyte | 0 | 1 | 12 | 16 | |
| 156 | Commuting transport | SOCIO000004 | 27.29 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 157 | PLG levels | PROLV001577 | 27.24 | Protein levels | Granulosa cell | 46 | 5 | 14 | 28 | |
| 158 | F11 levels | PROLV000741 | 27.17 | Protein levels | Hepatocyte | 103 | 3 | 8 | 13 | |
| 159 | Foot surgery | MSKEL000046 | 27.16 | Musculoskeletal | Hematopoietic progenitor | 2 | 2 | 6 | 12 | |
| 160 | KIAA0040 levels | PROLV001136 | 27.08 | Protein levels | Stromal / connective | 0 | 2 | 8 | 14 | |
| 161 | ANGPTL2 levels | PROLV000096 | 26.99 | Protein levels | Stromal / connective | 48 | 3 | 17 | 12 | |
| 162 | Lipid unsaturation | LIPID000079 | 26.39 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 163 | Other ear disorder | AUDIO000004 | 26.33 | Auditory | Epithelial | 6 | 0 | 7 | 9 | |
| 164 | VGF levels | PROLV002161 | 26.31 | Protein levels | Hepatocyte | 30 | 1 | 5 | 9 | |
| 165 | Fracture fixation | MSKEL000047 | 26.11 | Musculoskeletal | B / plasma cell | 0 | 2 | 9 | 16 | |
| 166 | Body fat percentage | BCOMP000004 | 26.07 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 167 | Benign prostatic hyperplasia | REPRO000011 | 25.97 | Reproductive | Respiratory epithelium | 25 | 0 | 5 | 7 | |
| 168 | Wellbeing | PSYCH000056 | 25.90 | Psychiatric | Neural / glial | 2 | 2 | 8 | 17 | |
| 169 | Family history, diabetes | METBL000009 | 25.89 | Metabolic | Hematopoietic progenitor | 0 | 1 | 1 | 5 | |
| 170 | Drink temperature | DTSUP000003 | 25.83 | Diet and Supplement | Neural / glial | 42 | 3 | 5 | 9 | |
| 171 | SFRP4 levels | PROLV001846 | 25.63 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 172 | GPD1 levels | PROLV000921 | 25.53 | Protein levels | Neural / glial | 0 | 3 | 7 | 11 | |
| 173 | Seafood preference | DTSUP000016 | 25.38 | Diet and Supplement | Neural / glial | 76 | 3 | 5 | 10 | |
| 174 | PALM2 levels | PROLV001490 | 25.35 | Protein levels | Lymphocyte | 22 | 4 | 19 | 36 | |
| 175 | Digestive system symptoms | GASTR000044 | 25.25 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 176 | FAM13A levels | PROLV000759 | 25.12 | Protein levels | Neural / glial | 16 | 4 | 8 | 22 | |
| 177 | SERPINE1/SPARC ratio | PRORT001778 | 25.10 | Protein ratios | Muscle / cardiac | 1 | 2 | 6 | 13 | |
| 178 | Negative affect | PSYCH000030 | 25.01 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 179 | Valvular heart disease | CARDI000054 | 24.98 | Cardiac | Vascular | 15 | 5 | 9 | 24 | |
| 180 | Ganglion cell inner plexiform layer thickness | OPHTH000027 | 24.67 | Ophthalmic | Renal epithelium | 10 | 0 | 6 | 5 | |
| 181 | Transport mode | BEHAV000009 | 24.65 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 182 | Pain, joint | MSKEL000036 | 24.45 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 183 | IFIT2 levels | PROLV001016 | 24.24 | Protein levels | Myeloid | 17 | 5 | 9 | 20 | |
| 184 | CFD levels | PROLV000412 | 24.24 | Protein levels | Myeloid | 9 | 0 | 6 | 14 | |
| 185 | Uterine or vaginal bleeding | REPRO000044 | 24.22 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 186 | Family history, lung cancer | MALIG000039 | 24.18 | Malignancy | Lymphocyte | 7 | 2 | 7 | 21 | |
| 187 | Alcohol use disorder | PSYCH000044 | 24.01 | Psychiatric | Neural / glial | 2 | 3 | 5 | 12 | |
| 188 | ITGB1BP2/SKAP2 ratio | PRORT001387 | 23.96 | Protein ratios | Lymphocyte | 14 | 4 | 8 | 35 | |
| 189 | Aortic valve disease | CARDI000053 | 23.58 | Cardiac | Vascular | 83 | 5 | 9 | 17 | |
| 190 | Pregnancy termination | BEHAV000010 | 23.54 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 191 | IDI2 levels | PROLV001010 | 23.46 | Protein levels | Muscle / cardiac | 11 | 3 | 8 | 20 | |
| 192 | Sleep-related movement disorder | NEURO000016 | 23.45 | Neurologic | Pancreatic epithelium | 4 | 0 | 8 | 5 | |
| 193 | Breast disorder | BREAS000002 | 23.40 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 194 | LTA/LTBR ratio | PRORT001463 | 23.39 | Protein ratios | B / plasma cell | 14 | 1 | 7 | 32 | |
| 195 | CCN5 levels | PROLV000305 | 23.26 | Protein levels | Vascular | 15 | 0 | 5 | 12 | |
| 196 | Mood symptoms | PSYCH000029 | 23.19 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 197 | AIFM1/PLXNA4 ratio | PRORT000060 | 23.15 | Protein ratios | Hepatocyte | 9 | 2 | 10 | 26 | |
| 198 | PRKAR1A levels | PROLV001631 | 23.15 | Protein levels | Platelet | 0 | 5 | 11 | 23 | |
| 199 | CDKN1A/TXLNA ratio | PRORT000575 | 23.13 | Protein ratios | Myeloid | 15 | 4 | 12 | 14 | |
| 200 | CTBS levels | PROLV000554 | 23.11 | Protein levels | Stromal / connective | 57 | 3 | 10 | 20 | |
| 201 | Fruit preference | DTSUP000012 | 22.85 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 202 | Brain general volume | NIMAG000015 | 22.82 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 203 | Pain, generic | MSKEL000035 | 22.75 | Musculoskeletal | Neural / glial | 4 | 4 | 17 | 25 | |
| 204 | CALCOCO1 levels | PROLV000257 | 22.70 | Protein levels | Vascular | 7 | 1 | 2 | 13 | |
| 205 | Depressive symptoms | PSYCH000026 | 22.69 | Psychiatric | Neural / glial | 28 | 2 | 7 | 14 | |
| 206 | Hip circumference, adjusted for BMI | BMORP000005 | 22.31 | Body morphology | Stromal / connective | 326 | 5 | 6 | 10 | |
| 207 | Heme malignancy, Plasma cell | MALIG000046 | 22.18 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 208 | Severe mental illness | PSYCH000017 | 22.08 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 209 | Trunk fat percentage | BCOMP000018 | 22.07 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 210 | Dyslipidaemia | METBL000020 | 21.73 | Metabolic | Hepatocyte | 416 | 1 | 6 | 10 | |
| 211 | Erectile dysfunction | VASCU000048 | 21.59 | Vascular | Neural / glial | 0 | 4 | 5 | 15 | |
| 212 | Metabolic syndrome | METBL000015 | 21.56 | Metabolic | Neural / glial | 850 | 7 | 13 | 19 | |
| 213 | Dietary change, none | DTSUP000005 | 21.55 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 214 | Memory disorder | PSYCH000006 | 21.51 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 215 | ASGR1/GGT5 ratio | PRORT000148 | 21.43 | Protein ratios | Hepatocyte | 60 | 1 | 9 | 18 | |
| 216 | CALCOCO1/VPS53 ratio | PRORT000304 | 21.41 | Protein ratios | Epithelial | 0 | 2 | 13 | 39 | |
| 217 | BAIAP2 levels | PROLV000176 | 21.24 | Protein levels | Myeloid | 12 | 2 | 10 | 11 | |
| 218 | Dietary pattern | DTSUP000007 | 21.12 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 219 | Prospective memory | PSYCH000009 | 21.08 | Psychiatric | Neural / glial | 18 | 4 | 13 | 19 | |
| 220 | Implantable cardioverter-defibrillator | CARDI000050 | 21.07 | Cardiac | Muscle / cardiac | 18 | 2 | 5 | 10 | |
| 221 | Social activity | SOCIO000020 | 20.99 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 222 | Medication, anti-diabetic | METBL000024 | 20.90 | Metabolic | Hematopoietic progenitor | 156 | 1 | 3 | 7 | |
| 223 | NT5E levels | PROLV001441 | 20.87 | Protein levels | Hepatocyte | 96 | 1 | 10 | 9 | |
| 224 | MME levels | PROLV001320 | 20.76 | Protein levels | Hepatocyte | 134 | 1 | 5 | 9 | |
| 225 | Hearing difficulty, none | AUDIO000005 | 20.71 | Auditory | Neural / glial | 33 | 2 | 8 | 10 | |
| 226 | Consultant specialty, general medicine | MISCL000016 | 20.70 | Miscellaneous | Neural / glial | 2 | 2 | 4 | 6 | |
| 227 | Congenital malformation | REPRO000003 | 20.66 | Reproductive | Lymphocyte | 8 | 2 | 5 | 14 | |
| 228 | CCDC50 levels | PROLV000275 | 20.37 | Protein levels | B / plasma cell | 0 | 4 | 7 | 12 | |
| 229 | Soft tissue disorder | MSKEL000069 | 20.26 | Musculoskeletal | Neural / glial | 21 | 2 | 7 | 6 | |
| 230 | Immune cell marker, CD4 T cell | HEMAT000022 | 20.23 | Hematologic | Myeloid | 0 | 0 | 0 | 0 | |
| 231 | Hospital admission | MISCL000022 | 19.87 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 232 | Hypoxaemia | RESPI000029 | 19.83 | Respiratory | Vascular | 15 | 2 | 13 | 27 | |
| 233 | IGFBP6/MFAP5 ratio | PRORT001336 | 19.78 | Protein ratios | Vascular | 0 | 2 | 11 | 19 | |
| 234 | ADM/CLMP ratio | PRORT000045 | 19.77 | Protein ratios | B / plasma cell | 16 | 2 | 6 | 8 | |
| 235 | Macular puckering of retina | OPHTH000037 | 19.63 | Ophthalmic | Stromal / connective | 17 | 3 | 8 | 11 | |
| 236 | MMP13 levels | PROLV001324 | 19.44 | Protein levels | Stromal / connective | 0 | 1 | 4 | 5 | |
| 237 | Placental weight | REPRO000026 | 19.29 | Reproductive | Hepatocyte | 59 | 3 | 8 | 17 | |
| 238 | Nerve root and plexus disorder | NEURO000029 | 19.15 | Neurologic | Myeloid | 0 | 2 | 8 | 12 | |
| 239 | Exophthalmic conditions | OPHTH000018 | 19.14 | Ophthalmic | Adipose | — | 2 | 9 | 12 | |
| 240 | Heel quantitative ultrasound | MSKEL000005 | 19.06 | Musculoskeletal | Stromal / connective | 361 | 3 | 8 | 12 | |
| 241 | Alcohol preference | PSYCH000042 | 19.05 | Psychiatric | Neural / glial | 14 | 4 | 10 | 11 | |
| 242 | FAM3D levels | PROLV000768 | 18.86 | Protein levels | Epithelial | 7 | 0 | 5 | 8 | |
| 243 | CDKN1A levels | PROLV000382 | 18.78 | Protein levels | Vascular | 59 | 1 | 5 | 13 | |
| 244 | Inflammation and poor diet | MISCL000001 | 18.73 | Miscellaneous | Myeloid | 166 | 5 | 8 | 19 | |
| 245 | OBP2B levels | PROLV001460 | 18.72 | Protein levels | Respiratory epithelium | 12 | 0 | 8 | 9 | |
| 246 | ACE2/MME ratio | PRORT000012 | 18.71 | Protein ratios | Hepatocyte | 40 | 1 | 5 | 9 | |
| 247 | ANXA11 levels | PROLV000106 | 18.66 | Protein levels | Stromal / connective | 26 | 2 | 5 | 15 | |
| 248 | BCAN/NCAN ratio | PRORT000218 | 18.66 | Protein ratios | Granulosa cell | 5 | 5 | 8 | 16 | |
| 249 | Anxiety | PSYCH000022 | 18.66 | Psychiatric | Neural / glial | 45 | 4 | 8 | 19 | |
| 250 | GGT1/MME ratio | PRORT001214 | 18.63 | Protein ratios | Hepatocyte | 39 | 1 | 5 | 12 | |
| 251 | MAMDC2 levels | PROLV001258 | 18.58 | Protein levels | Stromal / connective | 36 | 5 | 8 | 14 | |
| 252 | Testicular dysfunction | REPRO000016 | 18.56 | Reproductive | Hepatocyte | 14 | 3 | 12 | 33 | |
| 253 | MIA/NBL1 ratio | PRORT001532 | 18.54 | Protein ratios | Stromal / connective | 22 | 3 | 7 | 17 | |
| 254 | Grain and bakery preference | DTSUP000013 | 18.54 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 255 | Social support | SOCIO000022 | 18.53 | Socioeconomic | Neural / glial | 21 | 5 | 9 | 15 | |
| 256 | Pregnancy complication, obstructed labour | REPRO000031 | 18.51 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 257 | MFAP5 levels | PROLV001306 | 18.46 | Protein levels | Vascular | 14 | 2 | 7 | 13 | |
| 258 | AIFM1/SIRT2 ratio | PRORT000061 | 18.45 | Protein ratios | Hepatocyte | 13 | 1 | 7 | 13 | |
| 259 | Physical activity | BEHAV000007 | 18.39 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 260 | Medication, analgesic | MISCL000034 | 18.36 | Miscellaneous | Neural / glial | 28 | 4 | 8 | 28 | |
| 261 | ADH4/KRT18 ratio | PRORT000040 | 18.30 | Protein ratios | Hepatocyte | 12 | 1 | 11 | 17 | |
| 262 | Anaemia of chronic disease | HEMAT000002 | 18.16 | Hematologic | Hepatocyte | 4 | 3 | 6 | 15 | |
| 263 | PENK levels | PROLV001535 | 18.16 | Protein levels | Myeloid | 19 | 1 | 4 | 11 | |
| 264 | SPTLC1 levels | PROLV001941 | 18.11 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 265 | Trauma exposure | PSYCH000054 | 17.98 | Psychiatric | Neural / glial | 32 | 2 | 6 | 14 | |
| 266 | Alcohol use | PSYCH000043 | 17.90 | Psychiatric | Neural / glial | 16 | 4 | 8 | 13 | |
| 267 | Mood disorder | PSYCH000028 | 17.87 | Psychiatric | Neural / glial | 8 | 5 | 10 | 11 | |
| 268 | Spine surgery | MSKEL000051 | 17.79 | Musculoskeletal | Stromal / connective | 0 | 2 | 7 | 14 | |
| 269 | Biliverdin | HPBIL000018 | 17.68 | Hepatopancreatobiliary | Lymphocyte | 0 | 0 | 10 | 17 | |
| 270 | Frailty, limited social support | SOCIO000017 | 17.58 | Socioeconomic | Neural / glial | 0 | 4 | 4 | 9 | |
| 271 | Chronic bronchitis | RESPI000010 | 17.42 | Respiratory | Neural / glial | 1 | 1 | 2 | 7 | |
| 272 | BCHE levels | PROLV000184 | 17.41 | Protein levels | Hepatocyte | 114 | 1 | 5 | 11 | |
| 273 | ALDH1A1/PKLR ratio | PRORT000079 | 17.28 | Protein ratios | Myeloid | 11 | 3 | 10 | 21 | |
| 274 | Intervertebral disc disorder | MSKEL000076 | 17.23 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 275 | APOF levels | PROLV000125 | 17.16 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 276 | Childhood maltreatment | PSYCH000052 | 17.14 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 277 | Meat preference | DTSUP000015 | 17.12 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 278 | FETUB levels | PROLV000790 | 17.10 | Protein levels | Hepatocyte | 44 | 1 | 7 | 7 | |
| 279 | Hearing loss | AUDIO000013 | 17.06 | Auditory | Neural / glial | 54 | 1 | 3 | 11 | |
| 280 | MFAP4 levels | PROLV001305 | 17.00 | Protein levels | Myeloid | 75 | 4 | 9 | 20 | |
| 281 | Spondylosis | MSKEL000081 | 16.94 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 282 | ROBO1/SPON1 ratio | PRORT001744 | 16.88 | Protein ratios | Vascular | 3 | 3 | 7 | 12 | |
| 283 | VSTM2L levels | PROLV002176 | 16.75 | Protein levels | Myeloid | 1 | 2 | 7 | 11 | |
| 284 | ADH4/SCLY ratio | PRORT000043 | 16.69 | Protein ratios | Hepatocyte | 18 | 4 | 15 | 30 | |
| 285 | Retinal thickness | OPHTH000043 | 16.68 | Ophthalmic | Neural / glial | 58 | 1 | 5 | 7 | |
| 286 | CEACAM16 levels | PROLV000388 | 16.63 | Protein levels | Hepatocyte | 128 | 1 | 7 | 11 | |
| 287 | ARF6 levels | PROLV000133 | 16.63 | Protein levels | Stromal / connective | 50 | 5 | 15 | 21 | |
| 288 | Memory function | PSYCH000007 | 16.62 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 | |
| 289 | TSTA3 levels | PROLV002118 | 16.60 | Protein levels | Vascular | 10 | 3 | 7 | 12 | |
| 290 | Housing tenure | SOCIO000012 | 16.60 | Socioeconomic | Neural / glial | 0 | 5 | 9 | 20 | |
| 291 | Fatty acids, polyunsaturated | LIPID000026 | 16.60 | Lipids | Hepatocyte | 953 | 2 | 7 | 12 | |
| 292 | Suicidal behaviour | PSYCH000037 | 16.56 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 293 | Vaccination | IMMUN000085 | 16.51 | Immunologic | Neural / glial | 10 | 5 | 10 | 12 | |
| 294 | Smoking behaviour | PSYCH000046 | 16.48 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 295 | Grey matter volume | NIMAG000023 | 16.37 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 296 | Age at onset of walking | NEURO000023 | 16.34 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 297 | Cholesterol, IDL | LIPID000005 | 16.29 | Lipids | Hepatocyte | 692 | 1 | 8 | 15 | |
| 298 | Cellulitis and abscess | IMMUN000055 | 16.25 | Immunologic | Neural / glial | 5 | 4 | 11 | 20 | |
| 299 | Cerebral ischaemia | VASCU000012 | 16.16 | Vascular | Neural / glial | 1 | 2 | 7 | 5 | |
| 300 | BST2/MME ratio | PRORT000254 | 16.16 | Protein ratios | Renal epithelium | 5 | 0 | 6 | 12 | |
| 301 | Cardiac strain rate | CARDI000006 | 16.16 | Cardiac | Muscle / cardiac | 0 | 2 | 3 | 5 | |
| 302 | CNTN5 levels | PROLV000479 | 16.15 | Protein levels | Myeloid | 1 | 4 | 6 | 13 | |
| 303 | FAM177A1 levels | PROLV000764 | 16.13 | Protein levels | Gastrointestinal epithelium | 10 | 1 | 7 | 14 | |
| 304 | Risk-taking behaviour | BEHAV000013 | 16.12 | Behavioural | Neural / glial | 77 | 5 | 7 | 24 | |
| 305 | Creativity | PSYCH000003 | 16.08 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 306 | INSL4 levels | PROLV001092 | 16.07 | Protein levels | Muscle / cardiac | 3 | 2 | 4 | 12 | |
| 307 | RNF146 levels | PROLV001744 | 15.98 | Protein levels | Muscle / cardiac | 0 | 1 | 3 | 18 | |
| 308 | Nephritis and nephropathy | NEPHR000010 | 15.98 | Nephrourologic | Muscle / cardiac | 0 | 1 | 4 | 7 | |
| 309 | MTHFSD levels | PROLV001347 | 15.93 | Protein levels | Stromal / connective | 2 | 2 | 4 | 9 | |
| 310 | ANCA-associated vasculitis | IMMUN000021 | 15.82 | Immunologic | Adipose | 2 | 0 | 1 | 4 | |
| 311 | DSG3/DSG4 ratio | PRORT000952 | 15.77 | Protein ratios | Cutaneous epithelium | 11 | 1 | 6 | 11 | |
| 312 | Peripheral neuropathy | NEURO000032 | 15.77 | Neurologic | Neural / glial | 38 | 2 | 4 | 8 | |
| 313 | NPHS2 levels | PROLV001422 | 15.77 | Protein levels | B / plasma cell | 1 | 0 | 3 | 7 | |
| 314 | Skin ulcer | DERMA000044 | 15.64 | Dermatologic | Granulosa cell | 1 | 1 | 2 | 6 | |
| 315 | Depression or anxiety | PSYCH000025 | 15.60 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 316 | Shoulder lesion | MSKEL000068 | 15.56 | Musculoskeletal | B / plasma cell | 22 | 1 | 5 | 15 | |
| 317 | Radiotherapy | MALIG000049 | 15.56 | Malignancy | Muscle / cardiac | 0 | 3 | 10 | 19 | |
| 318 | HSD11B1/SMPD1 ratio | PRORT001302 | 15.51 | Protein ratios | Hepatocyte | 78 | 1 | 6 | 17 | |
| 319 | Parental longevity | AGING000003 | 15.50 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 320 | CCL22 levels | PROLV000289 | 15.47 | Protein levels | Myeloid | 15 | 2 | 8 | 17 | |
| 321 | Fibromuscular dysplasia | VASCU000024 | 15.33 | Vascular | Stromal / connective | 1 | 3 | 6 | 11 | |
| 322 | Operation, cardiac | CARDI000046 | 15.32 | Cardiac | Muscle / cardiac | 20 | 2 | 5 | 7 | |
| 323 | Vitreous disorder | OPHTH000047 | 15.30 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 324 | MOG levels | PROLV001332 | 15.25 | Protein levels | Pancreatic epithelium | 7 | 0 | 6 | 13 | |
| 325 | Brain MRI signal intensity | NIMAG000003 | 15.24 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 326 | TJAP1 levels | PROLV002043 | 15.24 | Protein levels | Stromal / connective | 1 | 2 | 5 | 14 | |
| 327 | Gut microbial abundance, CAG-776 | GASTR000023 | 15.23 | Gastrointestinal | Neural / glial | 0 | 2 | 4 | 16 | |
| 328 | Triglycerides, IDL | LIPID000034 | 15.22 | Lipids | Hepatocyte | 918 | 2 | 9 | 15 | |
| 329 | Cancer, Respiratory system | MALIG000027 | 15.15 | Malignancy | Lymphocyte | 4 | 3 | 12 | 38 | |
| 330 | Corpus callosum volume | NIMAG000021 | 15.09 | Neuroimaging | Neural / glial | 35 | 1 | 3 | 10 | |
| 331 | YES1 levels | PROLV002205 | 15.08 | Protein levels | Hepatocyte | 28 | 2 | 6 | 13 | |
| 332 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 15.07 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 333 | ENO2 levels | PROLV000706 | 15.04 | Protein levels | Lymphocyte | 3 | 2 | 5 | 17 | |
| 334 | CA1/TGM2 ratio | PRORT000270 | 15.03 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 335 | Spondylopathy | MSKEL000080 | 15.03 | Musculoskeletal | Stromal / connective | 21 | 2 | 2 | 10 | |
| 336 | PON1 levels | PROLV001600 | 14.94 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 337 | Hippocampal volume | NIMAG000024 | 14.89 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 338 | Cholesterol, LDL free | LIPID000006 | 14.87 | Lipids | Hepatocyte | 1,130 | 1 | 8 | 11 | |
| 339 | Hospital discharge | MISCL000023 | 14.83 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 340 | Dietary preference | DTSUP000008 | 14.82 | Diet and Supplement | Neural / glial | 53 | 3 | 7 | 12 | |
| 341 | BPIFB2 levels | PROLV000211 | 14.77 | Protein levels | Hepatocyte | 112 | 1 | 6 | 17 | |
| 342 | Menopausal disorder | REPRO000020 | 14.65 | Reproductive | Hepatocyte | 0 | 5 | 9 | 25 | |
| 343 | Medication, lipid-lowering | METBL000028 | 14.64 | Metabolic | Hepatocyte | 589 | 1 | 7 | 4 | |
| 344 | IGSF9 levels | PROLV001040 | 14.61 | Protein levels | Hepatocyte | 63 | 3 | 9 | 17 | |
| 345 | BACH1/HEXIM1 ratio | PRORT000195 | 14.59 | Protein ratios | Muscle / cardiac | 0 | 2 | 10 | 16 | |
| 346 | Subcortical volume | NIMAG000026 | 14.57 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 347 | LACRT levels | PROLV001173 | 14.56 | Protein levels | Cutaneous epithelium | 32 | 1 | 8 | 13 | |
| 348 | Atrioventricular block | CARDI000028 | 14.55 | Cardiac | Muscle / cardiac | 7 | 4 | 6 | 19 | |
| 349 | CXCL3 levels | PROLV000583 | 14.54 | Protein levels | Stromal / connective | 18 | 2 | 5 | 5 | |
| 350 | Peak expiratory flow | RESPI000023 | 14.53 | Respiratory | Stromal / connective | 305 | 2 | 5 | 8 | |
| 351 | White matter microstructure | NIMAG000013 | 14.47 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 352 | GHR levels | PROLV000885 | 14.45 | Protein levels | Hepatocyte | 17 | 2 | 7 | 23 | |
| 353 | PMVK/RHOC ratio | PRORT001694 | 14.40 | Protein ratios | Vascular | 0 | 2 | 9 | 10 | |
| 354 | Diabetes, type 2 | METBL000034 | 14.39 | Metabolic | Hepatocyte | 723 | 0 | 3 | 5 | |
| 355 | Medication, antihypertensive | VASCU000031 | 14.34 | Vascular | Vascular | 332 | 2 | 4 | 9 | |
| 356 | Hypothyroidism, secondary | ENDOC000015 | 14.34 | Endocrine | B / plasma cell | 0 | 2 | 11 | 20 | |
| 357 | Episcleritis | OPHTH000004 | 14.31 | Ophthalmic | Muscle / cardiac | 0 | 2 | 7 | 14 | |
| 358 | GPR37 levels | PROLV000929 | 14.30 | Protein levels | Hepatocyte | 88 | 2 | 9 | 21 | |
| 359 | LRP11/ROR1 ratio | PRORT001461 | 14.28 | Protein ratios | Vascular | 0 | 0 | 4 | 10 | |
| 360 | NECTIN2 levels | PROLV001387 | 14.27 | Protein levels | Vascular | 34 | 0 | 5 | 13 | |
| 361 | Triglycerides, LDL | LIPID000035 | 14.26 | Lipids | Hepatocyte | 1,174 | 2 | 10 | 12 | |
| 362 | ALDH1A1/CA2 ratio | PRORT000077 | 14.20 | Protein ratios | Hepatocyte | 9 | 1 | 4 | 17 | |
| 363 | Venous insufficiency | VASCU000065 | 14.13 | Vascular | Neural / glial | 1 | 1 | 4 | 12 | |
| 364 | ITGBL1 levels | PROLV001117 | 14.12 | Protein levels | Vascular | 82 | 3 | 11 | 14 | |
| 365 | Retinal vascular disorder | OPHTH000044 | 14.11 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 366 | HIP1R levels | PROLV000970 | 14.09 | Protein levels | Myeloid | 1 | 2 | 12 | 23 | |
| 367 | Cerebrovascular disease | VASCU000013 | 14.07 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 368 | Consultant specialty, urology | MISCL000020 | 14.07 | Miscellaneous | Neural / glial | 3 | 0 | 8 | 6 | |
| 369 | Study participation | BEHAV000004 | 14.03 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 370 | Body size, childhood | BMORP000004 | 13.98 | Body morphology | Neural / glial | 188 | 2 | 5 | 5 | |
| 371 | CRYBB2 levels | PROLV000533 | 13.96 | Protein levels | B / plasma cell | 4 | 2 | 6 | 14 | |
| 372 | VSTM2B levels | PROLV002175 | 13.95 | Protein levels | Lymphocyte | — | 3 | 16 | 34 | |
| 373 | Emphysema | RESPI000011 | 13.93 | Respiratory | Hepatocyte | 1 | 1 | 7 | 16 | |
| 374 | Gut microbial abundance, Rubneribacter | GASTR000035 | 13.92 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 375 | Urinary retention | NEPHR000015 | 13.92 | Nephrourologic | Lymphocyte | 0 | 0 | 1 | 5 | |
| 376 | Height | BMORP000009 | 13.85 | Body morphology | Stromal / connective | 3,280 | 3 | 4 | 6 | |
| 377 | Gut microbial abundance, CAG-269 | GASTR000021 | 13.78 | Gastrointestinal | Lymphocyte | 0 | 1 | 4 | 7 | |
| 378 | HEXIM1/IKBKG ratio | PRORT001276 | 13.77 | Protein ratios | Vascular | 0 | 0 | 8 | 20 | |
| 379 | Hypertensive chronic kidney disease | NEPHR000002 | 13.76 | Nephrourologic | Hepatocyte | 12 | 1 | 5 | 12 | |
| 380 | MYOC/NOTCH3 ratio | PRORT001566 | 13.75 | Protein ratios | Hepatocyte | 9 | 1 | 8 | 24 | |
| 381 | CDKN1A/PLA2G4A ratio | PRORT000571 | 13.69 | Protein ratios | Vascular | 14 | 4 | 12 | 23 | |
| 382 | SIGLEC7 levels | PROLV001863 | 13.67 | Protein levels | Myeloid | 20 | 1 | 13 | 11 | |
| 383 | DNAJB14 levels | PROLV000631 | 13.63 | Protein levels | Muscle / cardiac | 12 | 2 | 3 | 16 | |
| 384 | COMP/THBS4 ratio | PRORT000714 | 13.63 | Protein ratios | Neural / glial | 1 | 5 | 15 | 26 | |
| 385 | EGFR levels | PROLV000687 | 13.56 | Protein levels | Adipose | 22 | 3 | 10 | 13 | |
| 386 | Family history, chronic disease | MISCL000009 | 13.46 | Miscellaneous | Vascular | 0 | 5 | 13 | 8 | |
| 387 | GSTA4 levels | PROLV000941 | 13.43 | Protein levels | Adipose | 0 | 2 | 16 | 26 | |
| 388 | Syncope | NEURO000025 | 13.41 | Neurologic | B / plasma cell | 0 | 1 | 6 | 10 | |
| 389 | Osteoarthritis, OA | MSKEL000012 | 13.38 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 390 | NPC2 levels | PROLV001419 | 13.36 | Protein levels | Myeloid | 24 | 1 | 5 | 9 | |
| 391 | KLK4 levels | PROLV001156 | 13.34 | Protein levels | Hepatocyte | 34 | 2 | 7 | 11 | |
| 392 | FKBP4/RWDD1 ratio | PRORT001154 | 13.31 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 5 | 5 | |
| 393 | Cholesteryl esters, IDL | LIPID000016 | 13.30 | Lipids | Hepatocyte | 572 | 1 | 8 | 17 | |
| 394 | Smoking dependency | PSYCH000047 | 13.29 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 395 | ANGPTL3/TFPI ratio | PRORT000099 | 13.27 | Protein ratios | Hepatocyte | 73 | 2 | 11 | 18 | |
| 396 | Cortical surface area | NIMAG000009 | 13.25 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 397 | RLN2 levels | PROLV001736 | 13.19 | Protein levels | Muscle / cardiac | 6 | 4 | 10 | 24 | |
| 398 | ACE2/GGT1 ratio | PRORT000011 | 13.19 | Protein ratios | Hepatocyte | 57 | 1 | 5 | 13 | |
| 399 | Corneal keratometry | OPHTH000006 | 13.18 | Ophthalmic | Stromal / connective | 298 | 3 | 5 | 8 | |
| 400 | Acquired foot deformities | MSKEL000052 | 13.16 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 401 | PROC levels | PROLV001637 | 13.15 | Protein levels | Hepatocyte | 164 | 2 | 6 | 14 | |
| 402 | Family history, coronary artery disease | VASCU000021 | 13.14 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 403 | GFRA3/LAYN ratio | PRORT001211 | 13.13 | Protein ratios | Adipose | 4 | 3 | 4 | 12 | |
| 404 | Medication, antimigraine | NEURO000011 | 13.06 | Neurologic | Neural / glial | 0 | 2 | 7 | 8 | |
| 405 | FAS levels | PROLV000770 | 13.03 | Protein levels | Muscle / cardiac | 1 | 1 | 5 | 9 | |
| 406 | Triglycerides x psychiatric interaction | LIPID000040 | 12.97 | Lipids | Hepatocyte | 86 | 2 | 7 | 21 | |
| 407 | CPA4 levels | PROLV000503 | 12.93 | Protein levels | Myeloid | 3 | 3 | 8 | 8 | |
| 408 | Synovium, tendon and bursa disorder | MSKEL000057 | 12.84 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 409 | AMBP/ASGR1 ratio | PRORT000084 | 12.84 | Protein ratios | Hepatocyte | 68 | 1 | 6 | 6 | |
| 410 | Fatty acids unsaturation | LIPID000032 | 12.74 | Lipids | Hepatocyte | 1,087 | 2 | 7 | 16 | |
| 411 | HLA-DRA levels | PROLV000975 | 12.74 | Protein levels | Myeloid | 117 | 3 | 8 | 14 | |
| 412 | RBM17 levels | PROLV001710 | 12.73 | Protein levels | Vascular | 9 | 0 | 3 | 10 | |
| 413 | CTSO levels | PROLV000567 | 12.69 | Protein levels | Myeloid | 112 | 2 | 11 | 27 | |
| 414 | Medication, chronic lung disease | RESPI000006 | 12.68 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 415 | Nerve entrapment syndrome | NEURO000028 | 12.68 | Neurologic | Stromal / connective | 19 | 4 | 7 | 12 | |
| 416 | COMP/DPP4 ratio | PRORT000709 | 12.63 | Protein ratios | Myeloid | 32 | 4 | 13 | 18 | |
| 417 | Heart failure | CARDI000007 | 12.63 | Cardiac | Muscle / cardiac | 37 | 2 | 3 | 10 | |
| 418 | Cataract | OPHTH000012 | 12.63 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 419 | Peripheral artery disease | VASCU000042 | 12.62 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 420 | ADGRG2/NRCAM ratio | PRORT000036 | 12.54 | Protein ratios | Epithelial | 20 | 3 | 10 | 12 | |
| 421 | Chest pain | CARDI000052 | 12.52 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 422 | ART3/RGMA ratio | PRORT000145 | 12.51 | Protein ratios | Muscle / cardiac | 17 | 3 | 8 | 15 | |
| 423 | COQ7 levels | PROLV000498 | 12.50 | Protein levels | Hepatocyte | 59 | 1 | 6 | 7 | |
| 424 | COL15A1 levels | PROLV000483 | 12.49 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 425 | ADH4/DCXR ratio | PRORT000039 | 12.48 | Protein ratios | Hepatocyte | 17 | 4 | 11 | 18 | |
| 426 | AMOT levels | PROLV000087 | 12.47 | Protein levels | Hepatocyte | 22 | 1 | 5 | 15 | |
| 427 | Cancer, Other | MALIG000023 | 12.46 | Malignancy | B / plasma cell | 0 | 2 | 12 | 21 | |
| 428 | FAP/LRRN1 ratio | PRORT001116 | 12.44 | Protein ratios | Muscle / cardiac | 42 | 5 | 15 | 34 | |
| 429 | SCGB3A1 levels | PROLV001787 | 12.35 | Protein levels | Respiratory epithelium | 31 | 0 | 5 | 12 | |
| 430 | TNN levels | PROLV002083 | 12.32 | Protein levels | Stromal / connective | 16 | 2 | 9 | 11 | |
| 431 | ZBTB17 levels | PROLV002210 | 12.32 | Protein levels | Muscle / cardiac | 8 | 4 | 9 | 21 | |
| 432 | Implant | MISCL000025 | 12.30 | Miscellaneous | Stromal / connective | 0 | 0 | 0 | 0 | |
| 433 | Bone mineral density | MSKEL000004 | 12.26 | Musculoskeletal | Stromal / connective | 350 | 3 | 8 | 10 | |
| 434 | SMOC2 levels | PROLV001900 | 12.23 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 435 | TCTN3 levels | PROLV002005 | 12.23 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 436 | EFEMP1/TGFBR3 ratio | PRORT000988 | 12.14 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 437 | ECG morphology, unadjusted | ECGRM000002 | 12.11 | Electrocardiogram | Muscle / cardiac | 478 | 2 | 4 | 6 | |
| 438 | Cerebral aneurysm | VASCU000004 | 12.11 | Vascular | Vascular | 0 | 0 | 1 | 5 | |
| 439 | Depression | PSYCH000024 | 12.09 | Psychiatric | Neural / glial | 57 | 3 | 8 | 12 | |
| 440 | MST1 levels | PROLV001344 | 12.09 | Protein levels | Hepatocyte | 131 | 3 | 6 | 10 | |
| 441 | Carotid intima-media thickness | VASCU000053 | 12.06 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 442 | CD109 levels | PROLV000309 | 12.03 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 443 | Fasciitis | MSKEL000063 | 12.03 | Musculoskeletal | Stromal / connective | 16 | 1 | 3 | 8 | |
| 444 | LAMP1 levels | PROLV001180 | 11.99 | Protein levels | Myeloid | 47 | 3 | 9 | 19 | |
| 445 | Fall risk | MSKEL000043 | 11.94 | Musculoskeletal | Stromal / connective | 1 | 0 | 5 | 10 | |
| 446 | Insomnia | PSYCH000038 | 11.90 | Psychiatric | Neural / glial | 63 | 2 | 6 | 14 | |
| 447 | PRR15 levels | PROLV001641 | 11.89 | Protein levels | Epithelial | 0 | 2 | 6 | 9 | |
| 448 | Bundle branch block | CARDI000029 | 11.87 | Cardiac | Muscle / cardiac | 13 | 3 | 6 | 11 | |
| 449 | Hospital stay | MISCL000024 | 11.86 | Miscellaneous | Neural / glial | 2 | 1 | 3 | 6 | |
| 450 | CRELD1 levels | PROLV000518 | 11.82 | Protein levels | Myeloid | 51 | 2 | 8 | 20 | |
| 451 | Medication, benign prostatic hyperplasia | REPRO000017 | 11.82 | Reproductive | Respiratory epithelium | 14 | 0 | 4 | 4 | |
| 452 | Phosphatidylinositols | LIPID000061 | 11.74 | Lipids | Granulosa cell | 20 | 2 | 2 | 10 | |
| 453 | Medication, heart failure | CARDI000044 | 11.73 | Cardiac | Hepatocyte | 0 | 3 | 6 | 20 | |
| 454 | Peripheral nerve disorder | NEURO000031 | 11.70 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 455 | Urinary system disorder | NEPHR000005 | 11.66 | Nephrourologic | Neural / glial | 1 | 2 | 7 | 9 | |
| 456 | FOXO3/MAP3K5 ratio | PRORT001178 | 11.64 | Protein ratios | Gastrointestinal epithelium | 0 | 1 | 11 | 19 | |
| 457 | PDP1 levels | PROLV001530 | 11.62 | Protein levels | Hepatocyte | 0 | 0 | 2 | 6 | |
| 458 | Chronic kidney disease | NEPHR000001 | 11.59 | Nephrourologic | Hepatocyte | 63 | 1 | 4 | 8 | |
| 459 | Fibroblastic disorder | MSKEL000064 | 11.54 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 460 | Medication, coronary artery disease | VASCU000037 | 11.48 | Vascular | Vascular | 121 | 5 | 8 | 17 | |
| 461 | Cortical thickness | NIMAG000010 | 11.41 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 462 | Lactase deficiency | METBL000002 | 11.40 | Metabolic | Vascular | 0 | 2 | 5 | 12 | |
| 463 | Fatty acids, saturated | LIPID000027 | 11.31 | Lipids | Hepatocyte | 696 | 1 | 7 | 12 | |
| 464 | Cholesterol, non-HDL | LIPID000012 | 11.30 | Lipids | Hepatocyte | 340 | 1 | 7 | 8 | |
| 465 | REG1A/TFF3 ratio | PRORT001731 | 11.29 | Protein ratios | Epithelial | 50 | 0 | 8 | 12 | |
| 466 | Diabetes, type 1 | IMMUN000012 | 11.26 | Immunologic | Lymphocyte | 291 | 2 | 14 | 6 | |
| 467 | MYOC levels | PROLV001363 | 11.25 | Protein levels | Vascular | 33 | 0 | 5 | 12 | |
| 468 | CEP85 levels | PROLV000403 | 11.24 | Protein levels | Lymphocyte | 9 | 2 | 11 | 30 | |
| 469 | Cholesterol, VLDL free | LIPID000008 | 11.24 | Lipids | Hepatocyte | 1,347 | 2 | 8 | 17 | |
| 470 | COL6A3/COLEC12 ratio | PRORT000695 | 11.21 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 471 | Insulin levels | METBL000040 | 11.17 | Metabolic | Hepatocyte | 83 | 1 | 4 | 8 | |
| 472 | Beverage preference | DTSUP000001 | 11.12 | Diet and Supplement | Neural / glial | 155 | 3 | 9 | 15 | |
| 473 | Pneumoconiosis | RESPI000015 | 11.09 | Respiratory | Stromal / connective | 0 | 1 | 5 | 10 | |
| 474 | Restless legs syndrome, RLS | NEURO000012 | 11.09 | Neurologic | Neural / glial | 2 | 1 | 6 | 9 | |
| 475 | TAB2 levels | PROLV001987 | 11.06 | Protein levels | Myeloid | 0 | 2 | 3 | 9 | |
| 476 | Tinnitus | AUDIO000014 | 11.00 | Auditory | Neural / glial | 2 | 4 | 8 | 12 | |
| 477 | Medication, insulin therapy | METBL000027 | 10.97 | Metabolic | Hematopoietic progenitor | 22 | 1 | 5 | 11 | |
| 478 | CALCOCO1/TJAP1 ratio | PRORT000303 | 10.94 | Protein ratios | Muscle / cardiac | 0 | 4 | 14 | 32 | |
| 479 | CDHR2 levels | PROLV000379 | 10.92 | Protein levels | Hepatocyte | 103 | 2 | 13 | 22 | |
| 480 | ADAMTS8/FAP ratio | PRORT000026 | 10.91 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 481 | NCK2/PLA2G4A ratio | PRORT001574 | 10.91 | Protein ratios | Granulosa cell | 1 | 4 | 15 | 24 | |
| 482 | PYDC1 levels | PROLV001689 | 10.91 | Protein levels | Cutaneous epithelium | 85 | 2 | 9 | 10 | |
| 483 | Cardiovascular age gap | CARDI000001 | 10.90 | Cardiac | Muscle / cardiac | 27 | 3 | 6 | 16 | |
| 484 | Dairy preference | DTSUP000011 | 10.84 | Diet and Supplement | Neural / glial | 85 | 4 | 5 | 20 | |
| 485 | Brain functional activity | NIMAG000001 | 10.79 | Neuroimaging | Hepatocyte | 9 | 0 | 1 | 6 | |
| 486 | Migraine | NEURO000010 | 10.78 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 487 | Financial satisfaction | SOCIO000024 | 10.78 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 488 | PCOLCE levels | PROLV001510 | 10.76 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 489 | Social activity, none | SOCIO000018 | 10.75 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 490 | Medication, GERD | GASTR000014 | 10.74 | Gastrointestinal | Neural / glial | 1 | 2 | 7 | 12 | |
| 491 | Consultant specialty, general surgery | MISCL000017 | 10.67 | Miscellaneous | Neural / glial | 3 | 2 | 4 | 10 | |
| 492 | Liver enzyme elevation | HPBIL000019 | 10.67 | Hepatopancreatobiliary | Myeloid | 3 | 2 | 6 | 24 | |
| 493 | Brain structural connectivity | NIMAG000007 | 10.64 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 494 | CRISP2 levels | PROLV000524 | 10.64 | Protein levels | Lymphocyte | 3 | 1 | 9 | 12 | |
| 495 | Connective tissue disorder | MSKEL000060 | 10.53 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 496 | FAP/THBS4 ratio | PRORT001117 | 10.52 | Protein ratios | Hepatocyte | 21 | 4 | 12 | 33 | |
| 497 | Housing type | SOCIO000013 | 10.42 | Socioeconomic | Neural / glial | — | 7 | 14 | 22 | |
| 498 | Vitamin D | METAB000078 | 10.38 | Metabolites | Hepatocyte | 336 | 1 | 5 | 8 | |
| 499 | Miscarriage | REPRO000038 | 10.34 | Reproductive | Lymphocyte | 0 | 2 | 15 | 31 | |
| 500 | APCS levels | PROLV000113 | 10.32 | Protein levels | Myeloid | 68 | 3 | 12 | 20 | |
| 501 | Smoking effects on COPD | RESPI000012 | 10.31 | Respiratory | Hepatocyte | 20 | 1 | 4 | 13 | |
| 502 | PYY levels | PROLV001690 | 10.30 | Protein levels | Neural / glial | 56 | 2 | 8 | 11 | |
| 503 | PAPPA levels | PROLV001495 | 10.27 | Protein levels | Hematopoietic progenitor | 59 | 1 | 5 | 8 | |
| 504 | RND3 levels | PROLV001743 | 10.27 | Protein levels | Hepatocyte | 16 | 2 | 10 | 23 | |
| 505 | Daytime napping | BEHAV000015 | 10.27 | Behavioural | Neural / glial | 81 | 5 | 11 | 25 | |
| 506 | Hyperlipidaemia | METBL000022 | 10.27 | Metabolic | Hepatocyte | 381 | 1 | 7 | 7 | |
| 507 | PGLS levels | PROLV001545 | 10.27 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 508 | Premature cardiac beat | CARDI000023 | 10.27 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 509 | TNFRSF11B/TNFSF11 ratio | PRORT001845 | 10.21 | Protein ratios | Hepatocyte | 18 | 1 | 9 | 11 | |
| 510 | Cholesterol, remnant | LIPID000013 | 10.16 | Lipids | Hepatocyte | 224 | 1 | 9 | 14 | |
| 511 | GKN1 levels | PROLV000891 | 10.15 | Protein levels | Vascular | 10 | 0 | 10 | 19 | |
| 512 | ADGRD1 levels | PROLV000041 | 10.14 | Protein levels | Hepatocyte | 47 | 5 | 12 | 15 | |
| 513 | CD300C/FOLR2 ratio | PRORT000423 | 10.14 | Protein ratios | Myeloid | 63 | 2 | 9 | 10 | |
| 514 | WASF1 levels | PROLV002185 | 10.12 | Protein levels | Myeloid | 2 | 1 | 1 | 7 | |
| 515 | Corns and callosities | DERMA000023 | 10.12 | Dermatologic | Cutaneous epithelium | 3 | 0 | 3 | 3 | |
| 516 | Hypercholesterolaemia | METBL000021 | 10.08 | Metabolic | Hepatocyte | 462 | 1 | 7 | 8 | |
| 517 | Medication, proton pump inhibitor | GASTR000017 | 10.07 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 518 | Coffee preference | DTSUP000002 | 10.07 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 519 | GRPEL1/MME ratio | PRORT001248 | 10.06 | Protein ratios | Hepatocyte | 24 | 1 | 6 | 6 | |
| 520 | RGMB/THY1 ratio | PRORT001738 | 10.04 | Protein ratios | Hepatocyte | 1 | 2 | 6 | 12 | |
| 521 | Diabetes, type 1 with complication | IMMUN000011 | 10.03 | Immunologic | Neural / glial | 14 | 0 | 2 | 7 | |
| 522 | ECG morphology, adjusted | ECGRM000001 | 10.00 | Electrocardiogram | Muscle / cardiac | 426 | 2 | 3 | 9 | |
| 523 | Body proportion | BMORP000019 | 10.00 | Body morphology | Stromal / connective | 71 | 3 | 8 | 8 | |
| 524 | Female genital inflammation | REPRO000008 | 9.99 | Reproductive | Neural / glial | 0 | 2 | 4 | 4 | |
| 525 | ASGR1 levels | PROLV000151 | 9.98 | Protein levels | Hepatocyte | 61 | 5 | 15 | 29 | |
| 526 | Forced expiratory volume, FEV | RESPI000019 | 9.98 | Respiratory | Stromal / connective | 370 | 1 | 5 | 13 | |
| 527 | RAB2B levels | PROLV001698 | 9.97 | Protein levels | Stromal / connective | 1 | 3 | 4 | 9 | |
| 528 | Cholesterol, VLDL | LIPID000009 | 9.96 | Lipids | Hepatocyte | 1,391 | 2 | 9 | 14 | |
| 529 | Ocular refraction | OPHTH000033 | 9.96 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 530 | F7/PROC ratio | PRORT001088 | 9.92 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 12 | |
| 531 | Supplement use, mineral or vitamin | DTSUP000026 | 9.91 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 532 | Asparagine | METAB000018 | 9.90 | Metabolites | Hepatocyte | 6 | 2 | 10 | 14 | |
| 533 | SPON1 levels | PROLV001936 | 9.90 | Protein levels | Vascular | 33 | 0 | 2 | 7 | |
| 534 | LGMN/TIMP1 ratio | PRORT001458 | 9.87 | Protein ratios | Myeloid | 8 | 2 | 7 | 17 | |
| 535 | CDKN1A/FXN ratio | PRORT000568 | 9.86 | Protein ratios | Hepatocyte | 19 | 2 | 10 | 18 | |
| 536 | GAL levels | PROLV000847 | 9.82 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 537 | Oedema | MISCL000012 | 9.79 | Miscellaneous | Lymphocyte | 13 | 2 | 8 | 38 | |
| 538 | Pelvic morphology | BMORP000021 | 9.77 | Body morphology | Stromal / connective | 54 | 3 | 5 | 6 | |
| 539 | MOG/SEZ6L ratio | PRORT001553 | 9.70 | Protein ratios | Myeloid | 7 | 2 | 9 | 13 | |
| 540 | PDGFA/SERPINE1 ratio | PRORT001635 | 9.68 | Protein ratios | Hematopoietic progenitor | 33 | 5 | 9 | 12 | |
| 541 | VSNL1 levels | PROLV002173 | 9.65 | Protein levels | Myeloid | 44 | 2 | 9 | 20 | |
| 542 | CTSC levels | PROLV000561 | 9.65 | Protein levels | Hepatocyte | 71 | 3 | 13 | 17 | |
| 543 | FST levels | PROLV000829 | 9.64 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 544 | Cholesterol, LDL | LIPID000007 | 9.62 | Lipids | Hepatocyte | 1,987 | 1 | 6 | 12 | |
| 545 | Total lipids, LDL | LIPID000076 | 9.61 | Lipids | Hepatocyte | 379 | 1 | 7 | 9 | |
| 546 | Fatty acids, linoleic acid | LIPID000022 | 9.61 | Lipids | Hepatocyte | 920 | 2 | 7 | 11 | |
| 547 | Liver volume | HPBIL000025 | 9.56 | Hepatopancreatobiliary | Myeloid | 26 | 4 | 13 | 12 | |
| 548 | EDA2R levels | PROLV000673 | 9.56 | Protein levels | B / plasma cell | 20 | 4 | 12 | 26 | |
| 549 | SLC39A5 levels | PROLV001881 | 9.55 | Protein levels | Hepatocyte | 133 | 4 | 11 | 29 | |
| 550 | ACY1/SCLY ratio | PRORT000021 | 9.55 | Protein ratios | Hepatocyte | 6 | 3 | 12 | 17 | |
| 551 | Brain neuroimaging feature | NIMAG000005 | 9.54 | Neuroimaging | Stromal / connective | 137 | 0 | 2 | 9 | |
| 552 | Heart rate, exercise | CARDI000017 | 9.52 | Cardiac | Muscle / cardiac | 19 | 6 | 12 | 25 | |
| 553 | Triglycerides, VLDL | LIPID000036 | 9.51 | Lipids | Hepatocyte | 1,580 | 3 | 8 | 16 | |
| 554 | LTA4H levels | PROLV001240 | 9.51 | Protein levels | Muscle / cardiac | 0 | 3 | 16 | 38 | |
| 555 | LRRC59 levels | PROLV001234 | 9.48 | Protein levels | Myeloid | 5 | 3 | 6 | 12 | |
| 556 | Autoimmune hepatitis | IMMUN000024 | 9.48 | Immunologic | Neural / glial | — | 3 | 16 | 30 | |
| 557 | ITGB1BP2/MED18 ratio | PRORT001384 | 9.46 | Protein ratios | Muscle / cardiac | 0 | 4 | 7 | 17 | |
| 558 | Corrective lens use | OPHTH000032 | 9.42 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 559 | Cerebral amyloid angiopathy | NEURO000003 | 9.42 | Neurologic | Vascular | 2 | 0 | 6 | 7 | |
| 560 | TST levels | PROLV002117 | 9.40 | Protein levels | Neural / glial | 2 | 2 | 5 | 15 | |
| 561 | Goitre | ENDOC000019 | 9.39 | Endocrine | Neural / glial | 28 | 0 | 1 | 8 | |
| 562 | B3GNT7 levels | PROLV000170 | 9.39 | Protein levels | Muscle / cardiac | 72 | 2 | 13 | 24 | |
| 563 | Cholesterol, free | LIPID000011 | 9.38 | Lipids | Hepatocyte | 300 | 1 | 6 | 17 | |
| 564 | Cholesteryl esters, VLDL | LIPID000018 | 9.37 | Lipids | Hepatocyte | 1,427 | 2 | 8 | 17 | |
| 565 | Cholesterol, total | LIPID000014 | 9.33 | Lipids | Hepatocyte | 1,261 | 1 | 6 | 10 | |
| 566 | IL12RB1 levels | PROLV001046 | 9.32 | Protein levels | Muscle / cardiac | 54 | 5 | 14 | 18 | |
| 567 | Consultant specialty, trauma and orthopaedics | MISCL000019 | 9.32 | Miscellaneous | Stromal / connective | 2 | 5 | 15 | 14 | |
| 568 | CALCOCO1/DCTN1 ratio | PRORT000294 | 9.24 | Protein ratios | Muscle / cardiac | 0 | 3 | 9 | 21 | |
| 569 | Cholesterol, IDL free | LIPID000004 | 9.23 | Lipids | Hepatocyte | 608 | 1 | 9 | 12 | |
| 570 | CD63/CLEC1B ratio | PRORT000485 | 9.22 | Protein ratios | Myeloid | 1 | 5 | 11 | 18 | |
| 571 | CLIP2/DNAJA2 ratio | PRORT000665 | 9.22 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 18 | |
| 572 | Acquired absence of organs | MISCL000027 | 9.20 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 573 | A1BG levels | PROLV000001 | 9.18 | Protein levels | Hepatocyte | 32 | 1 | 7 | 9 | |
| 574 | Fatty acids, omega-6 | LIPID000025 | 9.17 | Lipids | Hepatocyte | 1,066 | 1 | 7 | 10 | |
| 575 | Bacterial intestinal infection | IMMUN000052 | 9.14 | Immunologic | Neural / glial | 0 | 1 | 2 | 9 | |
| 576 | Fatty acids, monounsaturated | LIPID000023 | 9.14 | Lipids | Hepatocyte | 1,143 | 2 | 10 | 17 | |
| 577 | Cardiac pacemaker | CARDI000049 | 9.12 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 578 | GFER/MAVS ratio | PRORT001205 | 9.12 | Protein ratios | Myeloid | 0 | 3 | 9 | 14 | |
| 579 | PDGFA/SPARC ratio | PRORT001637 | 9.10 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 580 | C1QTNF1 levels | PROLV000224 | 9.08 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 581 | ECM1 levels | PROLV000672 | 9.05 | Protein levels | Muscle / cardiac | 18 | 4 | 13 | 49 | |
| 582 | Lipoprotein particles, IDL | LIPID000044 | 9.05 | Lipids | Hepatocyte | 254 | 1 | 6 | 14 | |
| 583 | Personal medical history | MISCL000011 | 9.05 | Miscellaneous | Neural / glial | 0 | 0 | 3 | 7 | |
| 584 | MSLN levels | PROLV001340 | 9.04 | Protein levels | Epithelial | 45 | 0 | 5 | 6 | |
| 585 | LCN2/PRTN3 ratio | PRORT001442 | 9.02 | Protein ratios | Myeloid | 25 | 3 | 10 | 13 | |
| 586 | Stroke | VASCU000017 | 9.02 | Vascular | Vascular | 37 | 2 | 4 | 11 | |
| 587 | Healthspan | AGING000004 | 9.02 | Aging | Hepatocyte | 12 | 1 | 12 | 12 | |
| 588 | PADI2 levels | PROLV001483 | 9.00 | Protein levels | B / plasma cell | 4 | 1 | 3 | 8 | |
| 589 | Arthropathy | MSKEL000013 | 8.96 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 590 | Exotropia | OPHTH000022 | 8.93 | Ophthalmic | Myeloid | 6 | 1 | 8 | 7 | |
| 591 | Glucose levels | METBL000037 | 8.92 | Metabolic | Hepatocyte | 1,438 | 1 | 6 | 8 | |
| 592 | FABP4 levels | PROLV000754 | 8.90 | Protein levels | Stromal / connective | 8 | 0 | 3 | 6 | |
| 593 | Angina pectoris | CARDI000039 | 8.88 | Cardiac | Vascular | 317 | 5 | 9 | 18 | |
| 594 | Medication, ACE inhibitor | VASCU000028 | 8.88 | Vascular | Vascular | 12 | 0 | 2 | 3 | |
| 595 | Amygdala volume | NIMAG000014 | 8.84 | Neuroimaging | Hepatocyte | 32 | 0 | 1 | 7 | |
| 596 | EHBP1 levels | PROLV000689 | 8.81 | Protein levels | Stromal / connective | 18 | 3 | 5 | 18 | |
| 597 | PRTN3 levels | PROLV001651 | 8.78 | Protein levels | Myeloid | 93 | 1 | 5 | 9 | |
| 598 | GAST levels | PROLV000857 | 8.76 | Protein levels | Salivary epithelium | 17 | 0 | 6 | 9 | |
| 599 | CEACAM19 levels | PROLV000389 | 8.74 | Protein levels | Cutaneous epithelium | 26 | 1 | 9 | 8 | |
| 600 | Operation, gastrointestinal | GASTR000039 | 8.74 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 601 | Ventricular volume | CARDI000015 | 8.71 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 602 | Spinal stenosis | MSKEL000078 | 8.70 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 603 | IGFBP2 levels | PROLV001029 | 8.68 | Protein levels | Muscle / cardiac | 58 | 2 | 4 | 14 | |
| 604 | Intestinal disorder | GASTR000012 | 8.65 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 605 | KYAT1 levels | PROLV001169 | 8.58 | Protein levels | Neural / glial | 2 | 2 | 8 | 16 | |
| 606 | TOMM20 levels | PROLV002086 | 8.57 | Protein levels | Stromal / connective | 7 | 4 | 8 | 14 | |
| 607 | Neoplasm, uncertain behaviour | MALIG000035 | 8.57 | Malignancy | Lymphocyte | 1 | 2 | 9 | 26 | |
| 608 | Total lipids, IDL | LIPID000075 | 8.52 | Lipids | Hepatocyte | 281 | 1 | 7 | 12 | |
| 609 | Aortic aneurysm | VASCU000002 | 8.41 | Vascular | Vascular | 163 | 5 | 11 | 20 | |
| 610 | Vestibular disorder | AUDIO000022 | 8.37 | Auditory | Neural / glial | 0 | 2 | 4 | 13 | |
| 611 | Movement disorder | NEURO000015 | 8.37 | Neurologic | Neural / glial | 43 | 2 | 7 | 11 | |
| 612 | ENO3 levels | PROLV000707 | 8.30 | Protein levels | Muscle / cardiac | 33 | 4 | 18 | 37 | |
| 613 | CCL16 levels | PROLV000282 | 8.29 | Protein levels | Hepatocyte | 117 | 2 | 8 | 16 | |
| 614 | CEACAM8/VNN2 ratio | PRORT000590 | 8.24 | Protein ratios | Myeloid | 39 | 2 | 8 | 13 | |
| 615 | Lipoprotein particles, LDL | LIPID000045 | 8.23 | Lipids | Hepatocyte | 493 | 1 | 8 | 11 | |
| 616 | CCL25 levels | PROLV000292 | 8.22 | Protein levels | Vascular | 127 | 0 | 2 | 11 | |
| 617 | NPTXR levels | PROLV001428 | 8.21 | Protein levels | Myeloid | 28 | 1 | 6 | 14 | |
| 618 | Retinal nerve fibre layer thickness | OPHTH000031 | 8.21 | Ophthalmic | Pancreatic epithelium | 8 | 0 | 3 | 8 | |
| 619 | CTSH levels | PROLV000565 | 8.20 | Protein levels | Hepatocyte | 29 | 2 | 8 | 17 | |
| 620 | BCAN/DPP6 ratio | PRORT000215 | 8.17 | Protein ratios | Stromal / connective | 0 | 5 | 11 | 20 | |
| 621 | HAO1 levels | PROLV000951 | 8.16 | Protein levels | Hepatocyte | 87 | 1 | 6 | 9 | |
| 622 | Gynaecomastia | BREAS000003 | 8.15 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 623 | Dietary restriction | DTSUP000009 | 8.13 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 624 | Upper respiratory tract disease | RESPI000042 | 8.13 | Respiratory | Lymphocyte | 13 | 2 | 19 | 32 | |
| 625 | CKAP4/LTBR ratio | PRORT000622 | 8.13 | Protein ratios | Muscle / cardiac | 17 | 1 | 6 | 18 | |
| 626 | PIK3IP1/TNFRSF1B ratio | PRORT001667 | 8.12 | Protein ratios | Myeloid | 41 | 3 | 16 | 28 | |
| 627 | Phospholipids, LDL | LIPID000050 | 8.11 | Lipids | Hepatocyte | 1,023 | 1 | 6 | 12 | |
| 628 | CDKN1A/FOXO1 ratio | PRORT000567 | 8.10 | Protein ratios | Myeloid | 15 | 4 | 11 | 22 | |
| 629 | Diabetes, type 2, autoimmune subtype | IMMUN000013 | 8.09 | Immunologic | Myeloid | — | 1 | 7 | 29 | |
| 630 | Viral wart | IMMUN000079 | 8.04 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 631 | ICA1/MVK ratio | PRORT001319 | 8.01 | Protein ratios | Hepatocyte | 5 | 1 | 7 | 7 | |
| 632 | FEV1/FVC ratio | RESPI000021 | 7.99 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 633 | Hypertensive heart disease | CARDI000038 | 7.99 | Cardiac | Vascular | 23 | 0 | 1 | 8 | |
| 634 | MAP2K6 levels | PROLV001267 | 7.98 | Protein levels | Muscle / cardiac | 13 | 5 | 13 | 22 | |
| 635 | SERPINA5 levels | PROLV001819 | 7.97 | Protein levels | Hepatocyte | 98 | 1 | 5 | 10 | |
| 636 | Kidney failure | NEPHR000013 | 7.95 | Nephrourologic | Hepatocyte | 61 | 1 | 4 | 5 | |
| 637 | PDCD6 levels | PROLV001518 | 7.92 | Protein levels | Muscle / cardiac | 54 | 3 | 13 | 24 | |
| 638 | CDH2 levels | PROLV000374 | 7.91 | Protein levels | Hepatocyte | 137 | 1 | 11 | 25 | |
| 639 | CNTNAP2/DPP10 ratio | PRORT000689 | 7.89 | Protein ratios | Vascular | 0 | 1 | 4 | 9 | |
| 640 | PRTN3/RETN ratio | PRORT001711 | 7.88 | Protein ratios | Myeloid | 11 | 1 | 5 | 7 | |
| 641 | Gut microbial abundance, Bifidobacterium | GASTR000019 | 7.85 | Gastrointestinal | B / plasma cell | 0 | 3 | 6 | 20 | |
| 642 | Thyrotoxicosis | ENDOC000024 | 7.84 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 643 | LCN2/PGLYRP1 ratio | PRORT001441 | 7.83 | Protein ratios | Lymphocyte | 75 | 3 | 16 | 48 | |
| 644 | SPINK6 levels | PROLV001931 | 7.83 | Protein levels | Cutaneous epithelium | 0 | 1 | 13 | 10 | |
| 645 | CKAP4/TNFRSF4 ratio | PRORT000624 | 7.82 | Protein ratios | Hepatocyte | 21 | 2 | 10 | 35 | |
| 646 | PLAUR/PRSS8 ratio | PRORT001679 | 7.80 | Protein ratios | Epithelial | 37 | 2 | 11 | 13 | |
| 647 | HRC levels | PROLV000987 | 7.80 | Protein levels | Stromal / connective | 43 | 5 | 12 | 32 | |
| 648 | KDR/VWF ratio | PRORT001402 | 7.79 | Protein ratios | Vascular | 8 | 2 | 7 | 14 | |
| 649 | Anal and rectal disorder | GASTR000001 | 7.79 | Gastrointestinal | Gastrointestinal epithelium | 1 | 0 | 7 | 4 | |
| 650 | FTCD levels | PROLV000832 | 7.77 | Protein levels | Hepatocyte | 62 | 1 | 8 | 22 | |
| 651 | EGFR/FAP ratio | PRORT001000 | 7.76 | Protein ratios | Adipose | 52 | 4 | 8 | 17 | |
| 652 | CDKN1A/ENO2 ratio | PRORT000566 | 7.74 | Protein ratios | Hepatocyte | 21 | 3 | 8 | 18 | |
| 653 | Cardiac conduction disorder | CARDI000030 | 7.72 | Cardiac | Muscle / cardiac | 14 | 3 | 6 | 13 | |
| 654 | Sinusitis | RESPI000039 | 7.71 | Respiratory | Lymphocyte | 11 | 2 | 13 | 30 | |
| 655 | Estradiol | ENDOC000006 | 7.69 | Endocrine | Hepatocyte | 16 | 3 | 9 | 17 | |
| 656 | NGRN levels | PROLV001402 | 7.66 | Protein levels | Myeloid | 0 | 3 | 9 | 13 | |
| 657 | Dementia | NEURO000019 | 7.66 | Neurologic | Myeloid | 90 | 1 | 2 | 7 | |
| 658 | Muscular dystrophy | MSKEL000028 | 7.63 | Musculoskeletal | Muscle / cardiac | 4 | 4 | 17 | 33 | |
| 659 | Weight change | BMORP000016 | 7.62 | Body morphology | Neural / glial | 0 | 1 | 7 | 21 | |
| 660 | Phospholipids, VLDL | LIPID000051 | 7.61 | Lipids | Hepatocyte | 1,563 | 2 | 8 | 19 | |
| 661 | CD300C/MANSC1 ratio | PRORT000427 | 7.55 | Protein ratios | Myeloid | 13 | 3 | 8 | 22 | |
| 662 | BCAN/MOG ratio | PRORT000217 | 7.54 | Protein ratios | Myeloid | 5 | 1 | 6 | 12 | |
| 663 | Major depressive disorder | PSYCH000027 | 7.52 | Psychiatric | Neural / glial | 0 | 2 | 6 | 6 | |
| 664 | MINDY1 levels | PROLV001315 | 7.51 | Protein levels | Stromal / connective | 8 | 3 | 5 | 11 | |
| 665 | IL1RAP levels | PROLV001062 | 7.51 | Protein levels | Hepatocyte | 96 | 2 | 12 | 13 | |
| 666 | Cardiovascular disease | CARDI000035 | 7.47 | Cardiac | Vascular | 145 | 3 | 8 | 11 | |
| 667 | APOB levels | PROLV000120 | 7.46 | Protein levels | Hepatocyte | 618 | 1 | 7 | 9 | |
| 668 | PEPD levels | PROLV001536 | 7.46 | Protein levels | Myeloid | 66 | 2 | 7 | 7 | |
| 669 | SESTD1 levels | PROLV001838 | 7.44 | Protein levels | Muscle / cardiac | 12 | 4 | 8 | 23 | |
| 670 | PLIN3 levels | PROLV001579 | 7.44 | Protein levels | Muscle / cardiac | 0 | 6 | 11 | 22 | |
| 671 | PSAPL1 levels | PROLV001654 | 7.41 | Protein levels | Cutaneous epithelium | 66 | 0 | 14 | 13 | |
| 672 | Glutamine | METAB000021 | 7.40 | Metabolites | Hepatocyte | 401 | 2 | 9 | 18 | |
| 673 | TANK levels | PROLV001992 | 7.38 | Protein levels | Stromal / connective | 1 | 5 | 12 | 33 | |
| 674 | Alpha-1-antitrypsin deficiency | RESPI000005 | 7.38 | Respiratory | Granulosa cell | 4 | 3 | 10 | 14 | |
| 675 | NTPROBNP levels | PROLV001446 | 7.38 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 676 | FAM20A levels | PROLV000765 | 7.37 | Protein levels | Myeloid | 136 | 3 | 11 | 18 | |
| 677 | FLRT2/GFRA3 ratio | PRORT001161 | 7.37 | Protein ratios | Granulosa cell | 18 | 2 | 10 | 21 | |
| 678 | IGFBP1 levels | PROLV001028 | 7.36 | Protein levels | Hepatocyte | 15 | 1 | 7 | 11 | |
| 679 | PLAT levels | PROLV001571 | 7.35 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 680 | PIK3AP1/PSMG3 ratio | PRORT001664 | 7.34 | Protein ratios | Lymphocyte | 1 | 1 | 6 | 9 | |
| 681 | CETN3 levels | PROLV000409 | 7.34 | Protein levels | Platelet | 15 | 3 | 5 | 14 | |
| 682 | CHI3L1/PRSS8 ratio | PRORT000611 | 7.33 | Protein ratios | Myeloid | 7 | 5 | 11 | 23 | |
| 683 | CCDC80/CCL27 ratio | PRORT000332 | 7.33 | Protein ratios | Myeloid | 40 | 3 | 6 | 28 | |
| 684 | Coronary artery disease, CAD | VASCU000020 | 7.32 | Vascular | Vascular | 661 | 3 | 10 | 23 | |
| 685 | PON3 levels | PROLV001602 | 7.32 | Protein levels | Hepatocyte | 81 | 4 | 9 | 26 | |
| 686 | FSHB levels | PROLV000828 | 7.31 | Protein levels | Myeloid | 0 | 1 | 7 | 14 | |
| 687 | ACTA2 levels | PROLV000017 | 7.29 | Protein levels | Myeloid | 1 | 1 | 4 | 7 | |
| 688 | PPP1R12A/TXNDC5 ratio | PRORT001703 | 7.28 | Protein ratios | Hepatocyte | 10 | 3 | 10 | 31 | |
| 689 | ALDH1A1/CA3 ratio | PRORT000078 | 7.28 | Protein ratios | Myeloid | 27 | 5 | 10 | 28 | |
| 690 | PRKRA levels | PROLV001634 | 7.27 | Protein levels | Myeloid | 4 | 4 | 8 | 23 | |
| 691 | CASP3/LYN ratio | PRORT000314 | 7.27 | Protein ratios | Myeloid | 1 | 2 | 14 | 44 | |
| 692 | PRDX3 levels | PROLV001625 | 7.26 | Protein levels | Myeloid | 11 | 2 | 7 | 12 | |
| 693 | Aplastic anaemia | HEMAT000004 | 7.25 | Hematologic | Muscle / cardiac | 0 | 2 | 5 | 18 | |
| 694 | Gastrointestinal polyps | GASTR000005 | 7.25 | Gastrointestinal | Respiratory epithelium | 0 | 0 | 4 | 11 | |
| 695 | Medication, alcohol use disorder | PSYCH000018 | 7.24 | Psychiatric | B / plasma cell | 0 | 5 | 12 | 15 | |
| 696 | USP8 levels | PROLV002146 | 7.24 | Protein levels | Platelet | 2 | 5 | 6 | 11 | |
| 697 | Visual impairment | OPHTH000046 | 7.22 | Ophthalmic | Stromal / connective | 28 | 0 | 2 | 7 | |
| 698 | Pulmonary nodule | RESPI000018 | 7.20 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 699 | STK11/USP8 ratio | PRORT001819 | 7.17 | Protein ratios | Hepatocyte | 1 | 2 | 6 | 14 | |
| 700 | Medication, hypnotic or sedative | PSYCH000020 | 7.17 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 701 | PODXL2/SCG3 ratio | PRORT001695 | 7.16 | Protein ratios | Hepatocyte | 28 | 1 | 7 | 13 | |
| 702 | Ataxia | NEURO000013 | 7.14 | Neurologic | Neural / glial | 0 | 3 | 9 | 22 | |
| 703 | APP/NID2 ratio | PRORT000129 | 7.14 | Protein ratios | Stromal / connective | 0 | 2 | 6 | 11 | |
| 704 | Tryptophan metabolites | METAB000015 | 7.12 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 705 | NELL1 levels | PROLV001390 | 7.09 | Protein levels | Renal epithelium | 16 | 0 | 8 | 22 | |
| 706 | Cholesterol, esterified | LIPID000010 | 7.09 | Lipids | Hepatocyte | 379 | 2 | 8 | 13 | |
| 707 | TNC levels | PROLV002052 | 7.08 | Protein levels | Adipose | 35 | 2 | 6 | 11 | |
| 708 | CD93/CLEC14A ratio | PRORT000531 | 7.07 | Protein ratios | Neural / glial | 3 | 2 | 8 | 17 | |
| 709 | ITGA2 levels | PROLV001105 | 7.06 | Protein levels | Vascular | 76 | 3 | 13 | 27 | |
| 710 | SUOX levels | PROLV001977 | 7.05 | Protein levels | Hepatocyte | 27 | 1 | 13 | 31 | |
| 711 | Cholesteryl esters | LIPID000019 | 7.04 | Lipids | Neural / glial | 42 | 2 | 4 | 15 | |
| 712 | Sugar alcohols | METAB000037 | 7.04 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 713 | Biliary atresia | HPBIL000002 | 7.03 | Hepatopancreatobiliary | Stromal / connective | 0 | 2 | 8 | 6 | |
| 714 | GLB1 levels | PROLV000894 | 7.03 | Protein levels | Hepatocyte | 103 | 4 | 10 | 19 | |
| 715 | CXADR/MME ratio | PRORT000813 | 7.01 | Protein ratios | Epithelial | 21 | 1 | 3 | 6 | |
| 716 | Knee derangements | MSKEL000016 | 7.00 | Musculoskeletal | Stromal / connective | 5 | 1 | 2 | 7 | |
| 717 | MAP3K5 levels | PROLV001268 | 6.98 | Protein levels | Vascular | 0 | 1 | 4 | 12 | |
| 718 | Chronic respiratory disease | RESPI000003 | 6.98 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 719 | Shift work | SOCIO000008 | 6.97 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 | |
| 720 | DDAH1 levels | PROLV000607 | 6.97 | Protein levels | Myeloid | 3 | 7 | 10 | 19 | |
| 721 | MCEE levels | PROLV001284 | 6.97 | Protein levels | Myeloid | 2 | 3 | 11 | 27 | |
| 722 | GAPDH levels | PROLV000853 | 6.96 | Protein levels | Muscle / cardiac | 0 | 3 | 9 | 33 | |
| 723 | ITGB1/TFPI ratio | PRORT001381 | 6.96 | Protein ratios | Hepatocyte | 52 | 1 | 14 | 13 | |
| 724 | SLPI levels | PROLV001892 | 6.94 | Protein levels | Cutaneous epithelium | 0 | 0 | 11 | 9 | |
| 725 | Low hand grip strength | MSKEL000032 | 6.93 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 726 | TF levels | PROLV002011 | 6.92 | Protein levels | Hepatocyte | 40 | 3 | 8 | 17 | |
| 727 | Family history, hypertension | VASCU000022 | 6.91 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 728 | Haemoglobin status | HEMAT000009 | 6.87 | Hematologic | Stromal / connective | 1 | 1 | 2 | 6 | |
| 729 | PAMR1 levels | PROLV001493 | 6.85 | Protein levels | Myeloid | 137 | 3 | 13 | 23 | |
| 730 | LTBP2/PDGFRA ratio | PRORT001465 | 6.84 | Protein ratios | Myeloid | 4 | 3 | 9 | 8 | |
| 731 | Intracranial volume | NIMAG000025 | 6.82 | Neuroimaging | Muscle / cardiac | 0 | 3 | 8 | 18 | |
| 732 | DOK2/GRAP2 ratio | PRORT000938 | 6.78 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 4 | 7 | |
| 733 | Upper gastrointestinal disorder | GASTR000054 | 6.78 | Gastrointestinal | Myeloid | 0 | 1 | 7 | 13 | |
| 734 | ENPP5 levels | PROLV000709 | 6.77 | Protein levels | Myeloid | 71 | 4 | 11 | 13 | |
| 735 | CLK2 levels | PROLV000460 | 6.76 | Protein levels | Hepatocyte | 11 | 2 | 7 | 20 | |
| 736 | PTPN1/TDRKH ratio | PRORT001717 | 6.75 | Protein ratios | Granulosa cell | 1 | 2 | 5 | 7 | |
| 737 | TEX101 levels | PROLV002010 | 6.72 | Protein levels | Pancreatic epithelium | 0 | 0 | 5 | 7 | |
| 738 | EFEMP1 levels | PROLV000679 | 6.72 | Protein levels | Hepatocyte | 115 | 1 | 5 | 11 | |
| 739 | Perivascular space burden | NIMAG000011 | 6.72 | Neuroimaging | Muscle / cardiac | 3 | 2 | 5 | 7 | |
| 740 | Nephritis | NEPHR000024 | 6.71 | Nephrourologic | Hepatocyte | 24 | 0 | 5 | 9 | |
| 741 | XPNPEP2 levels | PROLV002199 | 6.66 | Protein levels | Hepatocyte | 67 | 2 | 9 | 14 | |
| 742 | ESAM/LAMA4 ratio | PRORT001063 | 6.65 | Protein ratios | Vascular | 16 | 4 | 9 | 15 | |
| 743 | Hearing aid use | AUDIO000011 | 6.63 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 744 | Sputum production | RESPI000033 | 6.62 | Respiratory | Myeloid | 0 | 4 | 9 | 14 | |
| 745 | MAP4K5/TBCB ratio | PRORT001491 | 6.62 | Protein ratios | Neural / glial | 5 | 4 | 8 | 23 | |
| 746 | NPY levels | PROLV001429 | 6.59 | Protein levels | Hepatocyte | 131 | 2 | 6 | 21 | |
| 747 | Lens replacement | OPHTH000025 | 6.53 | Ophthalmic | Vascular | 12 | 2 | 13 | 17 | |
| 748 | GRPEL1 levels | PROLV000935 | 6.53 | Protein levels | Hepatocyte | 23 | 2 | 8 | 24 | |
| 749 | Gut microbial abundance, Provencibacterium | GASTR000032 | 6.53 | Gastrointestinal | Cutaneous epithelium | 0 | 1 | 12 | 9 | |
| 750 | Medication, musculoskeletal | MSKEL000026 | 6.48 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 5 | |
| 751 | SSC5D levels | PROLV001948 | 6.47 | Protein levels | Vascular | 40 | 3 | 14 | 12 | |
| 752 | Waist-hip ratio | BMORP000014 | 6.45 | Body morphology | Adipose | 523 | 3 | 5 | 10 | |
| 753 | SCARA3 levels | PROLV001779 | 6.45 | Protein levels | Epithelial | 0 | 1 | 16 | 30 | |
| 754 | CBLN4/RET ratio | PRORT000326 | 6.44 | Protein ratios | Vascular | 13 | 1 | 8 | 16 | |
| 755 | Polyamine metabolites | METAB000059 | 6.43 | Metabolites | Hepatocyte | 1 | 1 | 9 | 17 | |
| 756 | PLIN1 levels | PROLV001578 | 6.43 | Protein levels | Neural / glial | 0 | 2 | 3 | 12 | |
| 757 | FKBP5 levels | PROLV000810 | 6.42 | Protein levels | Muscle / cardiac | 14 | 2 | 5 | 18 | |
| 758 | Forced vital capacity, FVC | RESPI000020 | 6.39 | Respiratory | Stromal / connective | 487 | 4 | 6 | 8 | |
| 759 | Gut microbial abundance, Staphylococcus | GASTR000036 | 6.36 | Gastrointestinal | Lymphocyte | 0 | 1 | 6 | 11 | |
| 760 | ATP5IF1/LYN ratio | PRORT000159 | 6.36 | Protein ratios | B / plasma cell | 1 | 3 | 18 | 33 | |
| 761 | Choroid plexus volume | NIMAG000020 | 6.36 | Neuroimaging | Neural / glial | 0 | 0 | 1 | 3 | |
| 762 | Pulmonary fibrosis | RESPI000017 | 6.36 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 763 | HNRNPK levels | PROLV000982 | 6.35 | Protein levels | Lymphocyte | 0 | 4 | 10 | 31 | |
| 764 | AXIN1/CALCOCO1 ratio | PRORT000165 | 6.34 | Protein ratios | Granulosa cell | 3 | 4 | 14 | 33 | |
| 765 | Glycine | METAB000022 | 6.34 | Metabolites | Hepatocyte | 498 | 1 | 7 | 11 | |
| 766 | Pyruvate | METAB000069 | 6.33 | Metabolites | Hematopoietic progenitor | 6 | 1 | 3 | 6 | |
| 767 | GRN levels | PROLV000933 | 6.33 | Protein levels | Myeloid | 36 | 1 | 4 | 9 | |
| 768 | Complement system disorder | IMMUN000048 | 6.30 | Immunologic | Hepatocyte | 4 | 1 | 5 | 8 | |
| 769 | CPXM1/DKK1 ratio | PRORT000732 | 6.30 | Protein ratios | Hematopoietic progenitor | 9 | 3 | 10 | 9 | |
| 770 | FOLR2/MSR1 ratio | PRORT001169 | 6.29 | Protein ratios | Myeloid | 40 | 2 | 10 | 11 | |
| 771 | Lipoprotein particles, VLDL | LIPID000046 | 6.26 | Lipids | Hepatocyte | 1,175 | 2 | 8 | 20 | |
| 772 | RHOC/TBCB ratio | PRORT001740 | 6.25 | Protein ratios | Myeloid | 0 | 4 | 11 | 21 | |
| 773 | IKBKG levels | PROLV001041 | 6.24 | Protein levels | Hepatocyte | 7 | 1 | 5 | 13 | |
| 774 | Total lipids, VLDL | LIPID000077 | 6.24 | Lipids | Hepatocyte | 1,057 | 2 | 8 | 17 | |
| 775 | C1RL levels | PROLV000228 | 6.23 | Protein levels | Hepatocyte | 59 | 2 | 7 | 10 | |
| 776 | NTRK2 levels | PROLV001447 | 6.22 | Protein levels | Myeloid | 73 | 3 | 11 | 21 | |
| 777 | SNCA levels | PROLV001908 | 6.21 | Protein levels | Myeloid | 18 | 2 | 5 | 10 | |
| 778 | Phospholipid species | LIPID000064 | 6.18 | Lipids | Hepatocyte | 23 | 2 | 4 | 16 | |
| 779 | DNAJB1/SIRT2 ratio | PRORT000929 | 6.16 | Protein ratios | Hepatocyte | 54 | 1 | 9 | 7 | |
| 780 | ADH4/KYNU ratio | PRORT000041 | 6.16 | Protein ratios | Hepatocyte | 41 | 4 | 16 | 28 | |
| 781 | CCN1 levels | PROLV000301 | 6.16 | Protein levels | Hepatocyte | 100 | 2 | 10 | 18 | |
| 782 | SCGB3A2 levels | PROLV001788 | 6.15 | Protein levels | Respiratory epithelium | 35 | 2 | 9 | 16 | |
| 783 | CLUL1 levels | PROLV000468 | 6.15 | Protein levels | Hepatocyte | 71 | 4 | 9 | 27 | |
| 784 | Refractive errors | OPHTH000034 | 6.15 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 785 | AXIN1/MAP2K6 ratio | PRORT000174 | 6.12 | Protein ratios | Granulosa cell | 0 | 3 | 5 | 12 | |
| 786 | HMBS/PKLR ratio | PRORT001288 | 6.11 | Protein ratios | Lymphocyte | 29 | 1 | 15 | 23 | |
| 787 | NTF3 levels | PROLV001442 | 6.11 | Protein levels | Vascular | 1 | 3 | 8 | 14 | |
| 788 | Amino acid metabolism disorder | METBL000001 | 6.10 | Metabolic | Lymphocyte | 0 | 2 | 3 | 9 | |
| 789 | EXTL1 levels | PROLV000738 | 6.09 | Protein levels | Myeloid | 13 | 4 | 13 | 17 | |
| 790 | Hydrocephalus | NEURO000002 | 6.09 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 791 | C1R levels | PROLV000227 | 6.09 | Protein levels | Hepatocyte | 0 | 4 | 15 | 29 | |
| 792 | Female genital tract polyp | REPRO000009 | 6.08 | Reproductive | Stromal / connective | 2 | 3 | 18 | 49 | |
| 793 | SH2B3/TBL1X ratio | PRORT001784 | 6.08 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 26 | |
| 794 | Fatty acids, total | LIPID000029 | 6.07 | Lipids | Hepatocyte | 719 | 2 | 8 | 13 | |
| 795 | Ankle spacing width | MSKEL000056 | 6.05 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 796 | Osteochondrodysplasia | MSKEL000054 | 6.03 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 797 | LIPF levels | PROLV001216 | 5.99 | Protein levels | Epithelial | 5 | 0 | 1 | 2 | |
| 798 | KRT8 levels | PROLV001168 | 5.99 | Protein levels | Adipose | 0 | 0 | 3 | 3 | |
| 799 | ADH4/RBP5 ratio | PRORT000042 | 5.98 | Protein ratios | Myeloid | 18 | 2 | 10 | 14 | |
| 800 | PALM levels | PROLV001489 | 5.98 | Protein levels | Granulosa cell | 28 | 1 | 7 | 8 | |
| 801 | Total lipids, lipoprotein particles | LIPID000078 | 5.97 | Lipids | Hepatocyte | 314 | 1 | 7 | 15 | |
| 802 | MOG/RTBDN ratio | PRORT001552 | 5.97 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 803 | Operation, hernia | GASTR000040 | 5.97 | Gastrointestinal | Adipose | 21 | 2 | 5 | 9 | |
| 804 | Phospholipids, IDL | LIPID000049 | 5.92 | Lipids | Hepatocyte | 536 | 2 | 8 | 13 | |
| 805 | GFAP levels | PROLV000874 | 5.91 | Protein levels | Myeloid | 2 | 3 | 11 | 10 | |
| 806 | PFKM levels | PROLV001541 | 5.91 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 807 | FGF21 levels | PROLV000795 | 5.90 | Protein levels | Hepatocyte | 41 | 2 | 4 | 5 | |
| 808 | Family history, breast cancer | MALIG000038 | 5.88 | Malignancy | Myeloid | 0 | 1 | 4 | 8 | |
| 809 | MED18/SMAD1 ratio | PRORT001509 | 5.88 | Protein ratios | Hepatocyte | 2 | 4 | 15 | 37 | |
| 810 | IFNGR2 levels | PROLV001021 | 5.88 | Protein levels | Myeloid | 122 | 5 | 14 | 30 | |
| 811 | GSTA3/KRT18 ratio | PRORT001253 | 5.87 | Protein ratios | Myeloid | 6 | 1 | 7 | 9 | |
| 812 | Retinal vascular morphology | OPHTH000045 | 5.87 | Ophthalmic | Vascular | 253 | 2 | 5 | 7 | |
| 813 | SIL1 levels | PROLV001866 | 5.85 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 814 | CKAP4/IL4R ratio | PRORT000620 | 5.85 | Protein ratios | Hepatocyte | 33 | 2 | 13 | 18 | |
| 815 | Immune cell marker, CD8 T cell | HEMAT000023 | 5.84 | Hematologic | Lymphocyte | 17 | 2 | 18 | 40 | |
| 816 | Chronic illness or disability | MISCL000004 | 5.83 | Miscellaneous | Neural / glial | 10 | 5 | 14 | 24 | |
| 817 | Functional gastrointestinal disorder | GASTR000003 | 5.82 | Gastrointestinal | Neural / glial | 0 | 1 | 6 | 18 | |
| 818 | Sulfate | METAB000051 | 5.82 | Metabolites | Hematopoietic progenitor | 0 | 1 | 5 | 6 | |
| 819 | Hereditary haemolytic anaemia | HEMAT000010 | 5.81 | Hematologic | B / plasma cell | 0 | 1 | 7 | 5 | |
| 820 | Ceramides | LIPID000065 | 5.79 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 821 | RGS18 levels | PROLV001731 | 5.78 | Protein levels | Myeloid | 1 | 3 | 8 | 14 | |
| 822 | PPP1R14A levels | PROLV001614 | 5.77 | Protein levels | Neural / glial | 11 | 2 | 7 | 11 | |
| 823 | ZNRF4 levels | PROLV002214 | 5.76 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 824 | CLIC5 levels | PROLV000458 | 5.75 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 825 | Pre-existing hypertension, pregnancy | VASCU000044 | 5.74 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 826 | Snoring | RESPI000036 | 5.74 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 827 | Brain functional connectivity | NIMAG000002 | 5.72 | Neuroimaging | Neural / glial | 0 | 0 | 0 | 0 | |
| 828 | EPCAM/GPA33 ratio | PRORT001035 | 5.71 | Protein ratios | B / plasma cell | 22 | 0 | 5 | 4 | |
| 829 | CACNA2D3 levels | PROLV000250 | 5.66 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 830 | Dizziness and giddiness | AUDIO000020 | 5.66 | Auditory | Neural / glial | 0 | 4 | 14 | 32 | |
| 831 | Operation, reproductive | REPRO000042 | 5.65 | Reproductive | Hepatocyte | 9 | 0 | 3 | 7 | |
| 832 | Tyrosine | METAB000031 | 5.62 | Metabolites | Hepatocyte | 258 | 1 | 5 | 10 | |
| 833 | AXIN1/ITGB1BP2 ratio | PRORT000173 | 5.61 | Protein ratios | Myeloid | 19 | 5 | 16 | 18 | |
| 834 | Passive smoking | MISCL000007 | 5.61 | Miscellaneous | Neural / glial | 0 | 3 | 8 | 18 | |
| 835 | Hernia | GASTR000008 | 5.61 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 836 | ISLR2 levels | PROLV001101 | 5.60 | Protein levels | Granulosa cell | 65 | 4 | 11 | 16 | |
| 837 | Supplement use, mineral or vitamin, none | DTSUP000027 | 5.60 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 838 | GLOD4/HSPA1A ratio | PRORT001218 | 5.59 | Protein ratios | Myeloid | 20 | 4 | 13 | 19 | |
| 839 | Cholesteryl esters, LDL | LIPID000017 | 5.59 | Lipids | Hepatocyte | 834 | 1 | 8 | 13 | |
| 840 | MAPK9 levels | PROLV001271 | 5.58 | Protein levels | Vascular | 0 | 3 | 8 | 17 | |
| 841 | Flavour preference | DTSUP000022 | 5.57 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 842 | GFER levels | PROLV000875 | 5.53 | Protein levels | Muscle / cardiac | 1 | 4 | 11 | 27 | |
| 843 | Cancer, Lung | MALIG000019 | 5.51 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 844 | IRAK1 levels | PROLV001097 | 5.49 | Protein levels | Vascular | 10 | 3 | 10 | 15 | |
| 845 | FAM151A levels | PROLV000760 | 5.48 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 846 | C7 levels | PROLV000236 | 5.46 | Protein levels | Adipose | 12 | 2 | 11 | 27 | |
| 847 | Thrombocytopenia | HEMAT000026 | 5.46 | Hematologic | Myeloid | 52 | 1 | 2 | 7 | |
| 848 | TNC/VCAM1 ratio | PRORT001843 | 5.45 | Protein ratios | Adipose | 38 | 3 | 10 | 13 | |
| 849 | Patellar disorder | MSKEL000018 | 5.45 | Musculoskeletal | Neural / glial | 0 | 0 | 4 | 8 | |
| 850 | Labour complication | REPRO000037 | 5.44 | Reproductive | Stromal / connective | 0 | 1 | 4 | 7 | |
| 851 | Testosterone | ENDOC000010 | 5.43 | Endocrine | Hepatocyte | 939 | 2 | 6 | 23 | |
| 852 | ACVRL1/TNFRSF19 ratio | PRORT000017 | 5.42 | Protein ratios | Vascular | 20 | 2 | 7 | 15 | |
| 853 | MMP7 levels | PROLV001326 | 5.41 | Protein levels | Hepatocyte | 5 | 1 | 11 | 22 | |
| 854 | Peptic ulcer disease | GASTR000051 | 5.40 | Gastrointestinal | Vascular | 12 | 0 | 1 | 5 | |
| 855 | Triglycerides, total | LIPID000037 | 5.40 | Lipids | Hepatocyte | 2,195 | 3 | 7 | 16 | |
| 856 | MVK levels | PROLV001354 | 5.38 | Protein levels | Stromal / connective | 0 | 5 | 9 | 38 | |
| 857 | STAB2 levels | PROLV001956 | 5.38 | Protein levels | Granulosa cell | 78 | 2 | 11 | 19 | |
| 858 | Parkinson disease | NEURO000022 | 5.37 | Neurologic | Neural / glial | 25 | 6 | 11 | 24 | |
| 859 | CHRDL1 levels | PROLV000433 | 5.37 | Protein levels | B / plasma cell | 1 | 2 | 4 | 9 | |
| 860 | CA3/HMBS ratio | PRORT000280 | 5.35 | Protein ratios | B / plasma cell | 12 | 4 | 15 | 37 | |
| 861 | CPA2 levels | PROLV000502 | 5.34 | Protein levels | Pancreatic epithelium | 57 | 0 | 5 | 5 | |
| 862 | ADM levels | PROLV000051 | 5.32 | Protein levels | B / plasma cell | 52 | 1 | 6 | 13 | |
| 863 | CXADR levels | PROLV000574 | 5.32 | Protein levels | Hepatocyte | 49 | 1 | 5 | 14 | |
| 864 | AKR1B1 levels | PROLV000072 | 5.30 | Protein levels | Stromal / connective | 11 | 7 | 10 | 27 | |
| 865 | RILPL2 levels | PROLV001735 | 5.30 | Protein levels | Muscle / cardiac | 10 | 5 | 8 | 19 | |
| 866 | EPHA1 levels | PROLV000716 | 5.30 | Protein levels | Hepatocyte | 108 | 2 | 9 | 15 | |
| 867 | Medication, anti-obesity | METBL000026 | 5.29 | Metabolic | Neural / glial | 0 | 1 | 4 | 11 | |
| 868 | BTD levels | PROLV000218 | 5.28 | Protein levels | Hepatocyte | 77 | 3 | 11 | 13 | |
| 869 | DAB2/TBL1X ratio | PRORT000841 | 5.28 | Protein ratios | Granulosa cell | 1 | 5 | 12 | 35 | |
| 870 | FABP4/FGF21 ratio | PRORT001100 | 5.25 | Protein ratios | Hepatocyte | 48 | 1 | 7 | 13 | |
| 871 | Glomerular disease | NEPHR000006 | 5.25 | Nephrourologic | Adipose | 5 | 2 | 3 | 9 | |
| 872 | Malocclusion | DENTA000008 | 5.24 | Dental | Stromal / connective | 0 | 0 | 1 | 2 | |
| 873 | KRT19 levels | PROLV001166 | 5.23 | Protein levels | Respiratory epithelium | 46 | 0 | 11 | 7 | |
| 874 | EPHA2 levels | PROLV000717 | 5.22 | Protein levels | Epithelial | 41 | 0 | 4 | 2 | |
| 875 | SERPINA12 levels | PROLV001816 | 5.22 | Protein levels | Hepatocyte | 63 | 3 | 11 | 18 | |
| 876 | COL6A3/HSPG2 ratio | PRORT000697 | 5.22 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 877 | Osteoporosis | MSKEL000010 | 5.21 | Musculoskeletal | Stromal / connective | 5 | 3 | 5 | 21 | |
| 878 | BCR/VASH1 ratio | PRORT000230 | 5.18 | Protein ratios | Hepatocyte | 1 | 1 | 6 | 13 | |
| 879 | PTPN1 levels | PROLV001671 | 5.18 | Protein levels | Vascular | 7 | 4 | 7 | 22 | |
| 880 | Medication, antiplatelet | VASCU000032 | 5.17 | Vascular | Vascular | 78 | 1 | 5 | 9 | |
| 881 | PRTG levels | PROLV001650 | 5.12 | Protein levels | Hepatocyte | 34 | 4 | 11 | 17 | |
| 882 | F11R/PARK7 ratio | PRORT001072 | 5.08 | Protein ratios | Hepatocyte | 0 | 1 | 7 | 26 | |
| 883 | EFNA4/TNFRSF9 ratio | PRORT000992 | 5.08 | Protein ratios | B / plasma cell | 16 | 3 | 18 | 25 | |
| 884 | Impacted cerumen | AUDIO000002 | 5.07 | Auditory | Salivary epithelium | 1 | 1 | 8 | 14 | |
| 885 | DTNB levels | PROLV000659 | 5.06 | Protein levels | Muscle / cardiac | 0 | 2 | 6 | 24 | |
| 886 | Brain neuroimaging quality metric | NIMAG000006 | 5.04 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 887 | CD79B/ICAM3 ratio | PRORT000512 | 5.04 | Protein ratios | B / plasma cell | 22 | 2 | 8 | 6 | |
| 888 | Arrhythmia | CARDI000018 | 5.02 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 889 | ADH4/SORD ratio | PRORT000044 | 5.02 | Protein ratios | Hepatocyte | 24 | 2 | 12 | 24 | |
| 890 | Metabolon metabolite | METAB000076 | 5.01 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 891 | SCARA5/TNC ratio | PRORT001760 | 5.00 | Protein ratios | Granulosa cell | 39 | 2 | 9 | 13 | |
| 892 | Loneliness | PSYCH000055 | 4.99 | Psychiatric | Neural / glial | 1 | 2 | 10 | 17 | |
| 893 | SOD2 levels | PROLV001917 | 4.99 | Protein levels | Myeloid | 96 | 2 | 6 | 7 | |
| 894 | Sleep disorder | PSYCH000039 | 4.98 | Psychiatric | Neural / glial | 13 | 1 | 4 | 4 | |
| 895 | MAVS levels | PROLV001279 | 4.96 | Protein levels | Myeloid | 7 | 3 | 3 | 11 | |
| 896 | COL9A1 levels | PROLV000493 | 4.96 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 897 | HJV levels | PROLV000971 | 4.96 | Protein levels | Hepatocyte | 12 | 4 | 12 | 35 | |
| 898 | Stomach and duodenal disorder | GASTR000053 | 4.96 | Gastrointestinal | Muscle / cardiac | 6 | 4 | 7 | 18 | |
| 899 | Weight-to-muscle ratio | BCOMP000010 | 4.93 | Body composition | Neural / glial | 1 | 5 | 8 | 19 | |
| 900 | CEACAM1 levels | PROLV000387 | 4.92 | Protein levels | Hepatocyte | 47 | 1 | 6 | 11 | |
| 901 | LTA levels | PROLV001239 | 4.92 | Protein levels | Lymphocyte | 112 | 3 | 17 | 32 | |
| 902 | BTN2A1/LILRB4 ratio | PRORT000258 | 4.91 | Protein ratios | Myeloid | 77 | 3 | 10 | 14 | |
| 903 | ERBIN/LYN ratio | PRORT001049 | 4.91 | Protein ratios | Lymphocyte | 8 | 2 | 14 | 21 | |
| 904 | Paradoxical eczema | IMMUN000036 | 4.86 | Immunologic | Myeloid | 0 | 1 | 6 | 16 | |
| 905 | Handedness | BEHAV000003 | 4.85 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 906 | ANGPTL1 levels | PROLV000095 | 4.84 | Protein levels | Hepatocyte | 101 | 1 | 5 | 8 | |
| 907 | TOP1 levels | PROLV002087 | 4.83 | Protein levels | Hepatocyte | 36 | 3 | 12 | 18 | |
| 908 | AIFM1 levels | PROLV000069 | 4.81 | Protein levels | Myeloid | 10 | 3 | 10 | 17 | |
| 909 | Pregnancy complication, abortive | REPRO000027 | 4.81 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 910 | Mental disorder | PSYCH000013 | 4.80 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 911 | PROS1 levels | PROLV001640 | 4.79 | Protein levels | Hepatocyte | 37 | 1 | 6 | 9 | |
| 912 | Diabetes, gestational | METBL000031 | 4.79 | Metabolic | Hepatocyte | 48 | 1 | 5 | 5 | |
| 913 | Phosphatidates | LIPID000057 | 4.79 | Lipids | Melanocyte | 0 | 1 | 2 | 4 | |
| 914 | MCAM/NCAM1 ratio | PRORT001505 | 4.79 | Protein ratios | Adipose | 14 | 4 | 6 | 17 | |
| 915 | HBB levels | PROLV000955 | 4.76 | Protein levels | Hepatocyte | 847 | 1 | 9 | 7 | |
| 916 | CDKN1A/NCK2 ratio | PRORT000570 | 4.75 | Protein ratios | Vascular | 14 | 2 | 9 | 17 | |
| 917 | THY1 levels | PROLV002031 | 4.74 | Protein levels | B / plasma cell | 30 | 2 | 10 | 21 | |
| 918 | Myocardial infarction | CARDI000042 | 4.73 | Cardiac | Vascular | 343 | 3 | 9 | 12 | |
| 919 | Optic cup area | OPHTH000028 | 4.71 | Ophthalmic | Vascular | 5 | 3 | 9 | 14 | |
| 920 | ADH4 levels | PROLV000049 | 4.70 | Protein levels | Hepatocyte | 58 | 2 | 7 | 12 | |
| 921 | Auditory performance | AUDIO000009 | 4.70 | Auditory | Neural / glial | 0 | 4 | 11 | 26 | |
| 922 | Potassium | METAB000049 | 4.67 | Metabolites | Muscle / cardiac | 178 | 0 | 4 | 5 | |
| 923 | CLC/RNASE3 ratio | PRORT000625 | 4.67 | Protein ratios | Myeloid | 7 | 1 | 5 | 9 | |
| 924 | Substance use | PSYCH000049 | 4.66 | Psychiatric | Muscle / cardiac | 0 | 4 | 6 | 14 | |
| 925 | CALCOCO1/CRACR2A ratio | PRORT000293 | 4.65 | Protein ratios | Muscle / cardiac | 0 | 1 | 19 | 32 | |
| 926 | GBA1 levels | PROLV000859 | 4.64 | Protein levels | Myeloid | 0 | 2 | 8 | 20 | |
| 927 | Sleep apnoea | RESPI000035 | 4.63 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 928 | APOM/MCAM ratio | PRORT000119 | 4.61 | Protein ratios | Hepatocyte | 64 | 2 | 10 | 18 | |
| 929 | Fatty liver disease, nonalcoholic | HPBIL000031 | 4.61 | Hepatopancreatobiliary | Vascular | 19 | 1 | 7 | 16 | |
| 930 | Intelligence decline | PSYCH000005 | 4.60 | Psychiatric | Lymphocyte | 0 | 4 | 10 | 39 | |
| 931 | CEACAM8/RNASE3 ratio | PRORT000589 | 4.60 | Protein ratios | Hematopoietic progenitor | 2 | 3 | 4 | 11 | |
| 932 | Arterial dissection | VASCU000003 | 4.60 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 933 | KRT5 levels | PROLV001167 | 4.58 | Protein levels | Cutaneous epithelium | 11 | 0 | 11 | 17 | |
| 934 | PCDH12 levels | PROLV001505 | 4.58 | Protein levels | Neural / glial | 5 | 2 | 5 | 10 | |
| 935 | A body shape index, ABSI | BMORP000001 | 4.58 | Body morphology | Stromal / connective | 203 | 3 | 6 | 12 | |
| 936 | SSH3 levels | PROLV001949 | 4.58 | Protein levels | Stromal / connective | — | 1 | 10 | 6 | |
| 937 | FADD/MGLL ratio | PRORT001105 | 4.58 | Protein ratios | Hematopoietic progenitor | 12 | 0 | 4 | 12 | |
| 938 | AMBP levels | PROLV000085 | 4.57 | Protein levels | Epithelial | 92 | 1 | 4 | 11 | |
| 939 | Dentures | DENTA000006 | 4.57 | Dental | Neural / glial | 0 | 3 | 7 | 16 | |
| 940 | CDC37/PPP1R12A ratio | PRORT000540 | 4.55 | Protein ratios | Muscle / cardiac | 1 | 3 | 10 | 19 | |
| 941 | Ventricular mass | CARDI000012 | 4.54 | Cardiac | Muscle / cardiac | 10 | 3 | 10 | 25 | |
| 942 | CD40LG/SERPINE1 ratio | PRORT000453 | 4.54 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 943 | COMP levels | PROLV000496 | 4.54 | Protein levels | Myeloid | 133 | 3 | 11 | 17 | |
| 944 | Lysophosphatidylinositols | LIPID000056 | 4.53 | Lipids | Hepatocyte | 3 | 2 | 5 | 20 | |
| 945 | CD99/MMP3 ratio | PRORT000535 | 4.53 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 946 | Hypertriglyceridaemia | METBL000023 | 4.53 | Metabolic | Hepatocyte | 117 | 1 | 5 | 20 | |
| 947 | VPS37A levels | PROLV002166 | 4.52 | Protein levels | Hepatocyte | 40 | 2 | 6 | 17 | |
| 948 | Frailty, unhealthy lifestyle | BEHAV000002 | 4.49 | Behavioural | Myeloid | 5 | 5 | 9 | 16 | |
| 949 | THY1/TNFRSF21 ratio | PRORT001836 | 4.49 | Protein ratios | Lymphocyte | 1 | 1 | 4 | 6 | |
| 950 | DPP6/SEZ6L ratio | PRORT000947 | 4.47 | Protein ratios | Adipose | 8 | 3 | 10 | 14 | |
| 951 | LYN/SIRT2 ratio | PRORT001472 | 4.46 | Protein ratios | Lymphocyte | 5 | 1 | 5 | 11 | |
| 952 | GP5 levels | PROLV000916 | 4.45 | Protein levels | Lymphocyte | 1 | 4 | 10 | 27 | |
| 953 | IL10RB levels | PROLV001043 | 4.44 | Protein levels | Granulosa cell | 21 | 1 | 8 | 7 | |
| 954 | CPM/PCSK9 ratio | PRORT000731 | 4.44 | Protein ratios | Hepatocyte | 71 | 2 | 8 | 13 | |
| 955 | CA2/TGM2 ratio | PRORT000278 | 4.44 | Protein ratios | Epithelial | 17 | 3 | 7 | 15 | |
| 956 | Hypokalaemia | METBL000006 | 4.43 | Metabolic | Hepatocyte | 0 | 1 | 4 | 15 | |
| 957 | Triglycerides | LIPID000039 | 4.43 | Lipids | Hepatocyte | 33 | 1 | 3 | 13 | |
| 958 | PMVK/PRTFDC1 ratio | PRORT001693 | 4.41 | Protein ratios | Muscle / cardiac | 1 | 2 | 11 | 12 | |
| 959 | CD177 levels | PROLV000314 | 4.41 | Protein levels | Myeloid | 21 | 1 | 6 | 7 | |
| 960 | Acylcarnitines | METAB000038 | 4.39 | Metabolites | Hepatocyte | 0 | 0 | 0 | 0 | |
| 961 | CPXM1/SPARC ratio | PRORT000736 | 4.37 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 8 | 22 | |
| 962 | Alanine metabolite | METAB000001 | 4.36 | Metabolites | Gastrointestinal epithelium | 0 | 2 | 9 | 7 | |
| 963 | Upper respiratory inflammation | RESPI000041 | 4.36 | Respiratory | Muscle / cardiac | 1 | 1 | 1 | 9 | |
| 964 | Circulatory disorder | VASCU000025 | 4.36 | Vascular | Neural / glial | 1 | 1 | 5 | 14 | |
| 965 | CC2D1A/STIP1 ratio | PRORT000329 | 4.36 | Protein ratios | Granulosa cell | 0 | 5 | 12 | 26 | |
| 966 | APOM levels | PROLV000128 | 4.34 | Protein levels | Hepatocyte | 122 | 2 | 8 | 20 | |
| 967 | Prolapse, pelvic organ | REPRO000025 | 4.34 | Reproductive | Stromal / connective | 35 | 3 | 6 | 13 | |
| 968 | Urbanicity | SOCIO000029 | 4.33 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 969 | Circadian timing | BEHAV000014 | 4.30 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 970 | ENO2/SCRN1 ratio | PRORT001030 | 4.30 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 2 | 4 | |
| 971 | Pancreatitis | HPBIL000027 | 4.29 | Hepatopancreatobiliary | Hepatocyte | 57 | 0 | 1 | 7 | |
| 972 | PON2 levels | PROLV001601 | 4.29 | Protein levels | Hepatocyte | 91 | 2 | 9 | 17 | |
| 973 | NFE2 levels | PROLV001397 | 4.29 | Protein levels | Stromal / connective | 10 | 2 | 5 | 12 | |
| 974 | Aneurysm | VASCU000001 | 4.28 | Vascular | Hepatocyte | 141 | 4 | 8 | 22 | |
| 975 | GSTA1/PBLD ratio | PRORT001250 | 4.28 | Protein ratios | Hepatocyte | 65 | 3 | 13 | 30 | |
| 976 | CST3/CTSZ ratio | PRORT000780 | 4.27 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 14 | |
| 977 | CLEC4G/SEMA3F ratio | PRORT000663 | 4.27 | Protein ratios | Myeloid | 15 | 3 | 11 | 19 | |
| 978 | CPB2 levels | PROLV000505 | 4.27 | Protein levels | Myeloid | 66 | 3 | 9 | 16 | |
| 979 | NCAN levels | PROLV001379 | 4.25 | Protein levels | Myeloid | 72 | 3 | 4 | 12 | |
| 980 | Lung volume | RESPI000022 | 4.25 | Respiratory | Myeloid | 4 | 3 | 7 | 12 | |
| 981 | Facial nerve palsy | NEURO000026 | 4.23 | Neurologic | Neural / glial | 0 | 1 | 9 | 27 | |
| 982 | Oestrogen metabolite | ENDOC000009 | 4.23 | Endocrine | Hepatocyte | 6 | 2 | 8 | 12 | |
| 983 | Histidine | METAB000023 | 4.21 | Metabolites | Hepatocyte | 171 | 1 | 4 | 8 | |
| 984 | FSTL1 levels | PROLV000830 | 4.21 | Protein levels | Myeloid | 71 | 2 | 8 | 15 | |
| 985 | Menstrual disorder | REPRO000021 | 4.21 | Reproductive | Vascular | 6 | 0 | 2 | 3 | |
| 986 | GPNMB levels | PROLV000927 | 4.20 | Protein levels | Hepatocyte | 49 | 5 | 9 | 24 | |
| 987 | KHK levels | PROLV001135 | 4.20 | Protein levels | Hepatocyte | 45 | 3 | 16 | 39 | |
| 988 | Phenylalanine | METAB000027 | 4.20 | Metabolites | Hepatocyte | 104 | 1 | 4 | 10 | |
| 989 | TREM2 levels | PROLV002102 | 4.20 | Protein levels | Myeloid | 120 | 3 | 7 | 12 | |
| 990 | CPA1/PRSS2 ratio | PRORT000722 | 4.18 | Protein ratios | Pancreatic epithelium | 17 | 0 | 5 | 9 | |
| 991 | FIS1/HSPA1A ratio | PRORT001149 | 4.18 | Protein ratios | Hepatocyte | 34 | 3 | 9 | 20 | |
| 992 | CD300E/LILRA5 ratio | PRORT000432 | 4.16 | Protein ratios | Myeloid | 25 | 4 | 12 | 19 | |
| 993 | PODXL2/SDC1 ratio | PRORT001696 | 4.16 | Protein ratios | Hepatocyte | 33 | 2 | 8 | 13 | |
| 994 | LCN2/RETN ratio | PRORT001443 | 4.16 | Protein ratios | Myeloid | 41 | 2 | 8 | 14 | |
| 995 | Pancreas fat | HPBIL000028 | 4.16 | Hepatopancreatobiliary | Adipose | 11 | 0 | 5 | 6 | |
| 996 | IGSF8/NECTIN2 ratio | PRORT001339 | 4.13 | Protein ratios | Granulosa cell | 15 | 1 | 14 | 37 | |
| 997 | DOK2 levels | PROLV000642 | 4.13 | Protein levels | Platelet | 24 | 4 | 9 | 11 | |
| 998 | ERBIN/SNAP29 ratio | PRORT001051 | 4.12 | Protein ratios | Muscle / cardiac | 0 | 3 | 9 | 18 | |
| 999 | LCAT levels | PROLV001190 | 4.11 | Protein levels | Hepatocyte | 88 | 2 | 8 | 13 | |
| 1000 | PCDH17/TEK ratio | PRORT001627 | 4.11 | Protein ratios | Vascular | 19 | 2 | 7 | 8 |